<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Linezolid</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Linezolid">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Linezolid</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Linezolid</b> is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics.<span class="mw-ref" id="cite_ref-Roger2018_2-2"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2016_3-1"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant <i>Staphylococcus aureus</i> (MRSA).<span class="mw-ref" id="cite_ref-Roger2018_2-3"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-0"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The main uses are infections of the skin and pneumonia although it may be used for a variety of other infections including drug-resistant tuberculosis.<span class="mw-ref" id="cite_ref-AHFS2016_3-2"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-WHO2015Use_5-0"><a href="#cite_note-WHO2015Use-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is used either by injection into a vein or by mouth.<span class="mw-ref" id="cite_ref-AHFS2016_3-3"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>



<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Linezolid</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Linezolid.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Linezolid.svg.png" data-file-width="385" data-file-height="195" data-file-type="drawing" height="111" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Linezolid-from-xtal-2008-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Linezolid-from-xtal-2008-3D-balls.png" data-file-width="1100" data-file-height="446" data-file-type="bitmap" height="89" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>l</span><span>ɪ</span><span>ˈ</span><span>n</span><span>ɛ</span><span>z</span><span>əl</span><span>ɪ</span><span>d</span></span>,<span class="wrap"> </span>-<span style="border-bottom:1px dotted"><span>ˈ</span><span>n</span><span>eɪ</span><span>z</span></span>-/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Zyvox, Zyvoxid, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/linezolid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/linezolid.html'" tppabs="https://www.drugs.com/monograph/linezolid.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a602004.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a602004.html'" tppabs="https://medlineplus.gov/druginfo/meds/a602004.html" class="external text external">a602004</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Linezolid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Linezolid'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Linezolid" class="external text external">Linezolid</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Linezolid&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Linezolid&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Linezolid&SearchType=BasicSearch" class="external text external">Linezolid</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Intravenous infusion, by mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td><a href="2-Oxazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxazolidinone" title="Oxazolidinone" class="mw-redirect">Oxazolidinone</a> antibiotic</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>J01XX08<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J01XX08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J01XX08'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J01XX08" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>~100% (oral)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>Low (31%)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>liver (50–70%, CYP not<span>&nbsp;</span>involved)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>3–7<span>&nbsp;</span>hours;<span class="mw-ref" id="cite_ref-Roger2018_2-0"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> longer half-life in CSF than plasma<span class="mw-ref" id="cite_ref-Roger2018_2-1"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>non-kidney, kidney, and fecal<span class="mw-ref" id="cite_ref-AHFS2016_3-0"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>S</i>)-<i>N</i>-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=165800-03-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=165800-03-3'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=165800-03-3" class="external text external">165800-03-3</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/441401  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/441401'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/441401" class="external text external">441401</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00601  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00601'" tppabs="https://www.drugbank.ca/drugs/DB00601" class="external text external">DB00601</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.390139.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.390139.html'" tppabs="http://www.chemspider.com/Chemical-Structure.390139.html" class="external text external">390139</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=ISQ9I6J12J  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=ISQ9I6J12J'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=ISQ9I6J12J" class="external text external">ISQ9I6J12J</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00947  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00947'" tppabs="https://www.kegg.jp/entry/D00947" class="external text external">D00947</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/C08146  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/C08146'" tppabs="https://www.kegg.jp/entry/C08146" class="external text external">C08146</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63607  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63607'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63607" class="external text external">CHEBI:63607</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL126  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL126'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL126" class="external text external">ChEMBL126</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">NIAID ChemDB</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=070944  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=070944'" tppabs="https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=070944" class="external text external">070944</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>ZLD (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ZLD  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ZLD'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ZLD" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=ZLD&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=ZLD&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=ZLD&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID5046489  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID5046489'" tppabs="https://comptox.epa.gov/dashboard/DTXSID5046489" class="external text external">DTXSID5046489</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.121.520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.121.520'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.121.520" class="external text external">100.121.520</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>16</sub><span>H</span><sub>20</sub><span>F</span><span>N</span><sub>3</sub><span>O</span><sub>4</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">337.351</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1O%5BC%40%40H%5D%28CNC%28%3DO%29C%29CN1c3cc%28F%29c%28N2CCOCC2%29cc3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1O%5BC%40%40H%5D%28CNC%28%3DO%29C%29CN1c3cc%28F%29c%28N2CCOCC2%29cc3'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1O%5BC%40%40H%5D%28CNC%28%3DO%29C%29CN1c3cc%28F%29c%28N2CCOCC2%29cc3" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=850189766&page2=Linezolid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=850189766&page2=Linezolid'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=850189766&page2=Linezolid" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>When given for short periods, linezolid is a relatively safe antibiotic.<span class="mw-ref" id="cite_ref-Marino2007_6-0"><a href="#cite_note-Marino2007-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It can be used in people of all ages and in people with liver disease or poor kidney function.<span class="mw-ref" id="cite_ref-AHFS2016_3-4"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Common side effects with short-term use include headache, diarrhea, rash, and nausea.<span class="mw-ref" id="cite_ref-AHFS2016_3-5"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Serious side effects may include serotonin syndrome, bone marrow suppression, and high blood lactate levels, particularly when used for more than two weeks.<span class="mw-ref" id="cite_ref-AHFS2016_3-6"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-SFX2016_7-0"><a href="#cite_note-SFX2016-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> If used for longer periods it may cause  nerve damage, including optic nerve damage, which may be irreversible.<span class="mw-ref" id="cite_ref-SFX2016_7-1"><a href="#cite_note-SFX2016-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


<p>As a protein synthesis inhibitor, linezolid works by suppressing bacterial protein production.<span class="mw-ref" id="cite_ref-Swaney1998_8-0"><a href="#cite_note-Swaney1998-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> This either stops growth or results in bacterial death.<span class="mw-ref" id="cite_ref-AHFS2016_3-7"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Although many antibiotics work this way, the exact mechanism of action of linezolid appears to be unique in that it blocks the initiation of protein production, rather than one of the later steps.<span class="mw-ref" id="cite_ref-Swaney1998_8-1"><a href="#cite_note-Swaney1998-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> As of 2014, bacterial resistance to linezolid has remained low.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Linezolid is a member of the <a href="2-Oxazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Oxazolidone" title="2-Oxazolidone">oxazolidinone</a> class of medications.<span class="mw-ref" id="cite_ref-AHFS2016_3-8"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


<p>Linezolid was discovered in the mid 1990s, and was approved for commercial use in 2000.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_12-0"><a href="#cite_note-WHO21st-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Linezolid is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2016_3-9"><a href="#cite_note-AHFS2016-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It appears to be more cost-effective than alternatives such as <a href="Vancomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vancomycin" title="Vancomycin">vancomycin</a>, mostly because of the ability to switch from intravenous use to administration by mouth sooner.<span class="mw-ref" id="cite_ref-Grau2008_13-0"><a href="#cite_note-Grau2008-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>The main use of linezolid is the treatment of severe infections caused by aerobic Gram-positive bacteria that are resistant to other antibiotics; it should not be used against bacteria that are sensitive to drugs with a narrower spectrum of activity, such as penicillins and cephalosporins. In both the popular press and the scientific literature, linezolid has been called a "reserve antibiotic"—one that should be used sparingly so that it will remain effective as a drug of last resort against potentially intractable infections.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-Wilson_15-0"><a href="#cite_note-Wilson-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Bozdogan_16-0"><a href="#cite_note-Bozdogan-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>In the United States, the indications for linezolid use approved by the U.S. Food and Drug Administration (FDA) are the treatment of vancomycin-resistant <i>Enterococcus</i> <i>faecium</i> infections, with or without bacterial invasion of the bloodstream; nosocomial pneumonia (hospital-acquired) and community-acquired pneumonia caused by <i>S. aureus</i> or <i>S. pneumoniae</i>; complicated skin and skin structure infections (cSSSI) caused by susceptible bacteria, including diabetic foot infection, unless complicated by osteomyelitis (infection of the bone and bone marrow); and <i>uncomplicated</i> skin and soft tissue infections caused by <i>S. pyogenes</i> or <i>S. aureus</i>.<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-1"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The manufacturer advises against the use of linezolid for community-acquired pneumonia or <i>uncomplicated</i> skin and soft tissue infections caused by MRSA.<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-2"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In the United Kingdom, pneumonia and cSSSIs are the only indications noted in the product labeling.<span class="mw-ref" id="cite_ref-SPC_17-0"><a href="#cite_note-SPC-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>Linezolid appears to be as safe and effective for use in children and newborns as it is in adults.<span class="mw-ref" id="cite_ref-Herrmann_18-0"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Skin_and_soft_tissue_infections">Skin and soft tissue infections</h3></summary>
    
<p>A large meta-analysis of randomized controlled trials found linezolid to be more effective than glycopeptide antibiotics (such as vancomycin and <a href="Teicoplanin.htm" tppabs="https://ptable.com/wiki/compounds/A/Teicoplanin" title="Teicoplanin">teicoplanin</a>) and beta-lactam antibiotics in the treatment of skin and soft tissue infections (SSTIs) caused by Gram-positive bacteria,<span class="mw-ref" id="cite_ref-Falagas2008_19-0"><a href="#cite_note-Falagas2008-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> and smaller studies appear to confirm its superiority over teicoplanin in the treatment of all serious Gram-positive infections.<span class="mw-ref" id="cite_ref-Tascini_20-0"><a href="#cite_note-Tascini-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>In the treatment of diabetic foot infections, linezolid appears to be cheaper and more effective than vancomycin.<span class="mw-ref" id="cite_ref-Chow_21-0"><a href="#cite_note-Chow-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> In a 2004 open-label study, it was as effective as ampicillin/sulbactam and amoxicillin/clavulanic acid, and far superior in patients with foot ulcers and no osteomyelitis, but with significantly higher rates of adverse effects.<span class="mw-ref" id="cite_ref-Lipsky_22-0"><a href="#cite_note-Lipsky-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-Pigrau_23-0"><a href="#cite_note-Pigrau-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> A 2008 meta-analysis of 18 randomized controlled trials, however, found that linezolid treatment failed as often as other antibiotics, regardless of whether patients had osteomyelitis.<span class="mw-ref" id="cite_ref-Vardakas_24-0"><a href="#cite_note-Vardakas-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>

<p>Some authors have recommended that combinations of cheaper or more cost-effective drugs (such as <a href="Trimethoprim/sulfamethoxazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Co-trimoxazole" title="Co-trimoxazole" class="mw-redirect">co-trimoxazole</a> with <a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">rifampicin</a> or <a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">clindamycin</a>) be tried before linezolid in the treatment of SSTIs when susceptibility of the causative organism allows it.<span class="mw-ref" id="cite_ref-Pigrau_23-1"><a href="#cite_note-Pigrau-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pneumonia">Pneumonia</h3></summary>
    
<p>No significant difference appears in treatment success rates between linezolid, glycopeptides, or appropriate beta-lactam antibiotics in the treatment of pneumonia.<span class="mw-ref" id="cite_ref-Falagas2008_19-1"><a href="#cite_note-Falagas2008-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Clinical guidelines for the treatment of community-acquired pneumonia developed by the American Thoracic Society and the Infectious Diseases Society of America recommend that linezolid be reserved for cases in which MRSA has been confirmed as the causative organism, or when MRSA infection is suspected based on the clinical presentation.<span class="mw-ref" id="cite_ref-USCAPGuidelines_26-0"><a href="#cite_note-USCAPGuidelines-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> The guidelines of the British Thoracic Society do not recommend it as first-line treatment, but rather as an alternative to vancomycin.<span class="mw-ref" id="cite_ref-BTSCAPGuidelines_27-0"><a href="#cite_note-BTSCAPGuidelines-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> Linezolid is also an acceptable second-line treatment for community-acquired pneumococcal pneumonia when penicillin resistance is present.<span class="mw-ref" id="cite_ref-USCAPGuidelines_26-1"><a href="#cite_note-USCAPGuidelines-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>

<p>U.S. guidelines recommend either linezolid or vancomycin as the first-line treatment for hospital-acquired (nosocomial) MRSA pneumonia.<span class="mw-ref" id="cite_ref-USHAPGuideline_28-0"><a href="#cite_note-USHAPGuideline-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> Some studies have suggested that linezolid is better than vancomycin against nosocomial pneumonia, particularly ventilator-associated pneumonia caused by MRSA, perhaps because the penetration of linezolid into bronchial fluids is much higher than that of vancomycin. Several issues in study design have been raised, however, calling into question results that suggest the superiority of linezolid.<span class="mw-ref" id="cite_ref-Pigrau_23-2"><a href="#cite_note-Pigrau-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Regardless, linezolid's advantages include its high oral bioavailability—which allows easy switching to oral therapy—and the fact that poor kidney function is not an obstacle to use.<span class="mw-ref" id="cite_ref-USHAPGuideline_28-1"><a href="#cite_note-USHAPGuideline-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> In contrast, achieving the correct dosage of vancomycin in patients with kidney failure is very difficult.<span class="mw-ref" id="cite_ref-USHAPGuideline_28-2"><a href="#cite_note-USHAPGuideline-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other">Other</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Endocarditis_ultrasound.JPG" tppabs="https://ptable.com/wiki/compounds/I/m/Endocarditis_ultrasound.JPG" data-file-width="2091" data-file-height="1425" data-file-type="bitmap" height="150" width="220"><div class="thumbcaption" style="text-align: left">This echocardiogram shows vegetations on the tricuspid valve (white arrow) caused by infective endocarditis. The patient received conventional treatment, with <a href="Ampicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ampicillin" title="Ampicillin">ampicillin</a>, <a href="Imipenem.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipenem" title="Imipenem">imipenem</a>, and glucocorticoids, and recovered fully after heart surgery.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></div></div></div>

<p>It is traditionally believed that so-called "deep" infections—such as osteomyelitis or infective endocarditis—should be treated with bactericidal antibiotics, not bacteriostatic ones. Nevertheless, preclinical studies were conducted to assess the efficacy of linezolid for these infections,<span class="mw-ref" id="cite_ref-Barbachyn_30-0"><a href="#cite_note-Barbachyn-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> and the drug has been used successfully to treat them in clinical practice. Linezolid appears to be a reasonable therapeutic option for infective endocarditis caused by multi-resistant Gram-positive bacteria, despite a lack of high-quality evidence to support this use.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-Falagas_32-0"><a href="#cite_note-Falagas-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Results in the treatment of enterococcal endocarditis have varied, with some cases treated successfully and others not responding to therapy.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Low- to medium-quality evidence is also mounting for its use in bone and joint infections, including chronic osteomyelitis, although adverse effects are a significant concern when long-term use is necessary.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-43"><a href="#cite_note-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>

<p>In combination with other drugs, linezolid has been used to treat tuberculosis.<span class="mw-ref" id="cite_ref-Lippea2006_45-0"><a href="#cite_note-Lippea2006-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> The optimal dose for this purpose has not been established.  In adults, daily and twice-daily dosing have been used to good effect. Many months of treatment are often required, and the rate of adverse effects is high regardless of dosage.<span class="mw-ref" id="cite_ref-Park2006_46-0"><a href="#cite_note-Park2006-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> There is not enough reliable evidence of efficacy and safety to support this indication as a routine use.<span class="mw-ref" id="cite_ref-Herrmann_18-1"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Linezolid has been studied as an alternative to vancomycin in the treatment of febrile neutropenia in cancer patients when Gram-positive infection is suspected.<span class="mw-ref" id="cite_ref-48"><a href="#cite_note-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> It is also one of few antibiotics that diffuse into the vitreous humor, and may therefore be effective in treating endophthalmitis (inflammation of the inner linings and cavities of the eye) caused by susceptible bacteria. Again, there is little evidence for its use in this setting, as infectious endophthalmitis is treated widely and effectively with vancomycin injected directly into the eye.<span class="mw-ref" id="cite_ref-Pigrau_23-3"><a href="#cite_note-Pigrau-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Infections_of_the_central_nervous_system">Infections of the central nervous system</h4></summary>
    
<p>In animal studies of meningitis caused by <i>Streptococcus pneumoniae</i>, linezolid was found to penetrate well into cerebrospinal fluid, but its effectiveness was inferior to that of other antibiotics.<span class="mw-ref" id="cite_ref-Moellering_49-0"><a href="#cite_note-Moellering-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-50"><a href="#cite_note-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> There does not appear to be enough high-quality evidence to support the routine use of linezolid to treat bacterial meningitis. Nonetheless, it has been used successfully in many cases of central nervous system infection—including meningitis—caused by susceptible bacteria, and has also been suggested as a reasonable choice for this indication when treatment options are limited or when other antibiotics have failed.<span class="mw-ref" id="cite_ref-Sabbatani_51-0"><a href="#cite_note-Sabbatani-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> The guidelines of the Infectious Diseases Society of America recommend linezolid as the first-line drug of choice for VRE meningitis, and as an alternative to vancomycin for MRSA meningitis.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> Linezolid appears superior to vancomycin in treating community-acquired MRSA infections of the central nervous system, although very few cases of such infections have been published (<span>as of 2009</span>).<span class="mw-ref" id="cite_ref-Naesens_54-0"><a href="#cite_note-Naesens-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Catheter-related_infections">Catheter-related infections</h4></summary>
    
<p>In March 2007, the FDA reported the results of a randomized, open-label, phase III clinical trial comparing linezolid to vancomycin in the treatment of catheter-related bloodstream infections. Patients treated with vancomycin could be switched to <a href="Oxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxacillin" title="Oxacillin">oxacillin</a> or <a href="Dicloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicloxacillin" title="Dicloxacillin">dicloxacillin</a> if the bacteria that caused their infection was found to be susceptible, and patients in both groups (linezolid and vancomycin) could receive specific treatment against Gram-negative bacteria if necessary.<span class="mw-ref" id="cite_ref-CRBSI_55-0"><a href="#cite_note-CRBSI-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> The study itself was published in January 2009.<span class="mw-ref" id="cite_ref-Wilcox_56-0"><a href="#cite_note-Wilcox-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span></p>

<p>Linezolid was associated with significantly greater mortality than the comparator antibiotics. When data from all participants were pooled, the study found that 21.5% of those given linezolid died, compared to 16% of those not receiving it. The difference was found to be due to the inferiority of linezolid in the treatment of Gram-negative infections alone or mixed Gram-negative/Gram-positive infections. In participants whose infection was due to Gram-positive bacteria alone, linezolid was as safe and effective as vancomycin.<span class="mw-ref" id="cite_ref-CRBSI_55-1"><a href="#cite_note-CRBSI-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span><span class="mw-ref" id="cite_ref-Wilcox_56-1"><a href="#cite_note-Wilcox-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> In light of these results, the FDA issued an alert reminding healthcare professionals that linezolid is not approved for the treatment of catheter-related infections or infections caused by Gram-negative organisms, and that more appropriate therapy should be instituted whenever a Gram-negative infection is confirmed or suspected.<span class="mw-ref" id="cite_ref-CRBSI_55-2"><a href="#cite_note-CRBSI-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Specific_populations">Specific populations</h3></summary>
    
<p>In adults and children over the age of 12, linezolid is usually given every 12 hours, whether orally or intravenously.<span class="mw-ref" id="cite_ref-Moellering_49-1"><a href="#cite_note-Moellering-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-American_Family_Physician_57-0"><a href="#cite_note-American_Family_Physician-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> In younger children and infants, it is given every eight hours.<span class="mw-ref" id="cite_ref-Buck_58-0"><a href="#cite_note-Buck-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> No dosage adjustments are required in the elderly, in people with mild-to-moderate liver failure, or in those with impaired kidney function.<span class="mw-ref" id="cite_ref-Lexi-Comp_59-0"><a href="#cite_note-Lexi-Comp-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> In people requiring hemodialysis, care should be taken to give linezolid after a session, because dialysis removes 30–40% of a dose from the body; no dosage adjustments are needed in people undergoing continuous hemofiltration,<span class="mw-ref" id="cite_ref-Lexi-Comp_59-1"><a href="#cite_note-Lexi-Comp-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> although more frequent administration may be warranted in some cases.<span class="mw-ref" id="cite_ref-Herrmann_18-2"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> According to one study, linezolid may need to be given more frequently than normal in people with burns affecting more than 20% of body area, due to increased nonrenal clearance of the drug.<span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span></p>

<p>Linezolid is in U.S. pregnancy category C, meaning there have been no adequate studies of its safety when used by pregnant women, and although animal studies have shown mild toxicity to the fetus, the benefits of using the drug may outweigh its risks.<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-3"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It also passes into breast milk, although the clinical significance of this (if any) is unknown.<span class="mw-ref" id="cite_ref-InfectiousDiseases_61-0"><a href="#cite_note-InfectiousDiseases-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Spectrum_of_activity">Spectrum of activity</h3></summary>
    
<style data-mw-deduplicate="TemplateStyles:r923042769/mw-parser-output/.tmulti">.mw-parser-output .tmulti .thumbinner{display:flex;flex-direction:column}.mw-parser-output .tmulti .trow{display:flex;flex-direction:row;clear:left;flex-wrap:wrap;width:100%;box-sizing:border-box}.mw-parser-output .tmulti .tsingle{margin:1px;float:left}.mw-parser-output .tmulti .theader{clear:both;font-weight:bold;text-align:center;align-self:center;background-color:transparent;width:100%}.mw-parser-output .tmulti .thumbcaption{text-align:left;background-color:transparent}.mw-parser-output .tmulti .thumbcaption-center{text-align:center;background-color:transparent}.mw-parser-output .tmulti .text-align-left{text-align:left}.mw-parser-output .tmulti .text-align-right{text-align:right}.mw-parser-output .tmulti .text-align-center{text-align:center}@media all and (max-width:720px){.mw-parser-output .tmulti .thumbinner{width:100%!important;box-sizing:border-box;max-width:none!important;align-items:center}.mw-parser-output .tmulti .trow{justify-content:center}.mw-parser-output .tmulti .tsingle{float:none!important;max-width:100%!important;box-sizing:border-box;text-align:center}.mw-parser-output .tmulti .thumbcaption{text-align:center}}</style><div class="thumb tmulti tright"><div class="thumbinner" style="width:204px;max-width:204px"><div class="trow"><div class="tsingle" style="width:202px;max-width:202px"><div class="thumbimage"><figure-inline><img src="../I/m/Vancomycin-Resistant_Enterococcus_01.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Vancomycin-Resistant_Enterococcus_01.jpg" data-file-width="2838" data-file-height="1910" data-file-type="bitmap" height="135" width="200"></figure-inline></div></div></div><div class="trow"><div class="tsingle" style="width:202px;max-width:202px"><div class="thumbimage"><figure-inline><img src="../I/m/CDC-10046-MRSA.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/CDC-10046-MRSA.jpg" data-file-width="2835" data-file-height="1927" data-file-type="bitmap" height="136" width="200"></figure-inline></div></div></div><div class="trow" style="display:flex"><div class="thumbcaption" style="background-color:transparent">Scanning electron micrographs of vancomycin-resistant <i>Enterococcus</i> (top) and methicillin-resistant <i>Staphylococcus aureus</i> (bottom; false colors)</div></div></div></div>
<p>Linezolid is effective against all clinically important Gram-positive bacteria—those whose cell wall contains a thick layer of peptidoglycan and no outer membrane—notably <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i> (including vancomycin-resistant enterococci), <i>Staphylococcus aureus</i> (including methicillin-resistant <i>Staphylococcus aureus</i>, MRSA), <i>Streptococcus agalactiae</i>, <i>Streptococcus pneumoniae</i>, <i>Streptococcus pyogenes</i>, the <i>viridans</i> group streptococci, <i>Listeria monocytogenes</i>, and <i>Corynebacterium</i> species (the latter being among the most susceptible to linezolid, with minimum inhibitory concentrations routinely below 0.5<span>&nbsp;</span>mg/L).<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-4"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Moellering_49-2"><a href="#cite_note-Moellering-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-Jones_62-0"><a href="#cite_note-Jones-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> Linezolid is also highly active <i>in vitro</i> against several mycobacteria.<span class="mw-ref" id="cite_ref-Moellering_49-3"><a href="#cite_note-Moellering-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> It appears to be very effective against <i>Nocardia</i>, but because of high cost and potentially serious adverse effects, authors have recommended that it be combined with other antibiotics or reserved for cases that have failed traditional treatment.<span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span></p>

<p>Linezolid is considered bacteriostatic against most organisms—that is, it stops their growth and reproduction without actually killing them—but has some bactericidal (killing) activity against streptococci.<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-5"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-DrugTherPerspect_64-0"><a href="#cite_note-DrugTherPerspect-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> Some authors have noted that, despite its bacteriostatic effect <i>in vitro</i>, linezolid "behaves" as a bactericidal antibiotic <i>in vivo</i> because it inhibits the production of toxins by staphylococci and streptococci.<span class="mw-ref" id="cite_ref-Barbachyn_30-1"><a href="#cite_note-Barbachyn-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> It also has a post-antibiotic effect lasting one to four hours for most bacteria, meaning that bacterial growth is temporarily suppressed even after the drug is discontinued.<span class="mw-ref" id="cite_ref-Herrmann_18-3"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Gram-negative_bacteria">Gram-negative bacteria</h4></summary>
    
<p>Linezolid has no clinically significant effect on most Gram-negative bacteria. <i>Pseudomonas</i> and the Enterobacteriaceae, for instance, are not susceptible.<span class="mw-ref" id="cite_ref-DrugTherPerspect_64-1"><a href="#cite_note-DrugTherPerspect-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> <i>In vitro</i>, it is active against <i>Pasteurella multocida</i>,<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-6"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-65"><a href="#cite_note-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> <i>Fusobacterium</i>, <i>Moraxella catarrhalis</i>, <i>Legionella</i>, <i>Bordetella</i>, and <i>Elizabethkingia meningoseptica</i>, and moderately active (having a minimum inhibitory concentration for 90% of strains of 8<span>&nbsp;</span>mg/L) against <i>Haemophilus influenzae</i>.<span class="mw-ref" id="cite_ref-InfectiousDiseases_61-1"><a href="#cite_note-InfectiousDiseases-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span><span class="mw-ref" id="cite_ref-DrugTherPerspect_64-2"><a href="#cite_note-DrugTherPerspect-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> It has also been used to great effect as a second-line treatment for <i>Capnocytophaga</i> infections.<span class="mw-ref" id="cite_ref-Sabbatani_51-1"><a href="#cite_note-Sabbatani-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-66"><a href="#cite_note-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Comparable_antibiotics">Comparable antibiotics</h4></summary>
    
<p>Linezolid's spectrum of activity against Gram-positive bacteria is similar to that of the glycopeptide antibiotic <a href="Vancomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vancomycin" title="Vancomycin">vancomycin</a>, which has long been the standard for treatment of MRSA infections, and the two drugs are often compared.<span class="mw-ref" id="cite_ref-Marino2007_6-1"><a href="#cite_note-Marino2007-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Herrmann_18-4"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Other comparable antibiotics include glycopeptide antibiotics such as <a href="Teicoplanin.htm" tppabs="https://ptable.com/wiki/compounds/A/Teicoplanin" title="Teicoplanin">teicoplanin</a> (trade name Targocid), dalbavancin (Dalvance), and telavancin (Vibativ); quinupristin/dalfopristin (Synercid, a combination of two streptogramins, not active against <i>E. faecalis</i>);<span class="mw-ref" id="cite_ref-Livermore_67-0"><a href="#cite_note-Livermore-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> <a href="Daptomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Daptomycin" title="Daptomycin">daptomycin</a> (Cubicin, a lipopeptide); and ceftobiprole (Zevtera, a 5th-generation cephalosporin). Linezolid is the only one that can be taken by mouth for the treatment of systemic infections.<span class="mw-ref" id="cite_ref-Herrmann_18-5"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> In the future, oritavancin and iclaprim may be useful oral alternatives to linezolid—both are in the early stages of clinical development.<span class="mw-ref" id="cite_ref-Herrmann_18-6"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>When used for short periods, linezolid is a relatively safe drug.<span class="mw-ref" id="cite_ref-Marino2007_6-2"><a href="#cite_note-Marino2007-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Common side effects of linezolid use (those occurring in more than 1% of people taking linezolid) include diarrhea (reported by 3–11% of clinical trial participants), headache (1–11%), nausea (3–10%), vomiting (1–4%), rash (2%), constipation (2%), altered taste perception (1–2%), and discoloration of the tongue (0.2–1%).<span class="mw-ref" id="cite_ref-Lexi-Comp_59-2"><a href="#cite_note-Lexi-Comp-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> Fungal infections such as thrush and vaginal candidiasis may also occur as linezolid suppresses normal bacterial flora and opens a niche for fungi (so-called antibiotic candidiasis).<span class="mw-ref" id="cite_ref-Lexi-Comp_59-3"><a href="#cite_note-Lexi-Comp-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> Less common (and potentially more serious) adverse effects include allergic reactions, pancreatitis, and elevated transaminases, which may be a sign of liver damage.<span class="mw-ref" id="cite_ref-Lexi-Comp_59-4"><a href="#cite_note-Lexi-Comp-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-French_68-0"><a href="#cite_note-French-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> Unlike some antibiotics, such as <a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">erythromycin</a> and the quinolones, linezolid has no effect on the QT interval, a measure of cardiac electrical conduction.<span class="mw-ref" id="cite_ref-French_68-1"><a href="#cite_note-French-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-Metaxas_69-0"><a href="#cite_note-Metaxas-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Adverse effects in children are similar to those that occur in adults.<span class="mw-ref" id="cite_ref-Metaxas_69-1"><a href="#cite_note-Metaxas-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span></p>

<p>Like nearly all antibiotics, linezolid has been associated with <i>Clostridium difficile</i>-associated diarrhea (CDAD) and pseudomembranous colitis, although the latter is uncommon, occurring in about one in two thousand patients in clinical trials.<span class="mw-ref" id="cite_ref-Lexi-Comp_59-5"><a href="#cite_note-Lexi-Comp-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-French_68-2"><a href="#cite_note-French-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-Metaxas_69-2"><a href="#cite_note-Metaxas-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span><span class="mw-ref" id="cite_ref-70"><a href="#cite_note-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span> <i>C. difficile</i> appears to be susceptible to linezolid <i>in vitro</i>, and linezolid was even considered as a possible treatment for CDAD.<span class="mw-ref" id="cite_ref-71"><a href="#cite_note-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Long-term_use">Long-term use</h3></summary>
    
<p>Bone marrow suppression, characterized particularly by thrombocytopenia (low platelet count), may occur during linezolid treatment; it appears to be the only adverse effect that occurs significantly more frequently with linezolid than with glycopeptides or beta-lactams.<span class="mw-ref" id="cite_ref-Falagas2008_19-2"><a href="#cite_note-Falagas2008-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> It is uncommon in patients who receive the drug for 14 days or fewer, but occurs much more frequently in patients who receive longer courses or who have renal failure.<span class="mw-ref" id="cite_ref-French_68-3"><a href="#cite_note-French-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-72"><a href="#cite_note-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> A 2004 case report suggested that <a href="Pyridoxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyridoxine" title="Pyridoxine">pyridoxine</a> (a form of vitamin B<sub>6</sub>) could reverse the anemia and thrombocytopenia caused by linezolid,<span class="mw-ref" id="cite_ref-73"><a href="#cite_note-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> but a later, larger study found no protective effect.<span class="mw-ref" id="cite_ref-74"><a href="#cite_note-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span></p>

<p>Long-term use of linezolid has also been associated with chemotherapy-induced peripheral neuropathy, a progressive and enduring often irreversible tingling numbness, intense pain, and hypersensitivity to cold, beginning in the hands and feet and sometimes involving the arms and legs.<span class="mw-ref" id="cite_ref-NCI_75-0"><a href="#cite_note-NCI-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> Chemotherapy drugs associated with CIPN include <a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">thalidomide</a>, the epothilones such as ixabepilone, the <i>vinca</i> alkaloids <a href="Vincristine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vincristine" title="Vincristine">vincristine</a> and <a href="Vinblastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vinblastine" title="Vinblastine">vinblastine</a>,<span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span><span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span><span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> the taxanes <a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">paclitaxel</a> and <a href="Docetaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Docetaxel" title="Docetaxel">docetaxel</a>, the proteasome inhibitors such as <a href="Bortezomib.htm" tppabs="https://ptable.com/wiki/compounds/A/Bortezomib" title="Bortezomib">bortezomib</a>, and the platinum-based drugs <a href="Cisplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisplatin" title="Cisplatin">cisplatin</a>, <a href="Oxaliplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaliplatin" title="Oxaliplatin">oxaliplatin</a> and <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Carboplatin  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Carboplatin'" tppabs="https://ptable.com/wiki/compounds/A/Carboplatin" title="Carboplatin">carboplatin</a>.<span class="mw-ref" id="cite_ref-NCI_75-1"><a href="#cite_note-NCI-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span><span class="mw-ref" id="cite_ref-79"><a href="#cite_note-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span><span class="mw-ref" id="cite_ref-80"><a href="#cite_note-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> and optic neuropathy, which is most common after several months of treatment and may also be irreversible.<span class="mw-ref" id="cite_ref-Narita_81-0"><a href="#cite_note-Narita-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-Bressler_82-0"><a href="#cite_note-Bressler-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span><span class="mw-ref" id="cite_ref-Brown_83-0"><a href="#cite_note-Brown-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span><span class="mw-ref" id="cite_ref-pmid17766431_84-0"><a href="#cite_note-pmid17766431-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span><span class="mw-ref" id="cite_ref-85"><a href="#cite_note-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span> Although the mechanism of injury is still poorly understood, mitochondrial toxicity has been proposed as a cause;<span class="mw-ref" id="cite_ref-Barnhill_86-0"><a href="#cite_note-Barnhill-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span><span class="mw-ref" id="cite_ref-Javaheri_87-0"><a href="#cite_note-Javaheri-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span> linezolid is toxic to mitochondria, probably because of the similarity between mitochondrial and bacterial ribosomes.<span class="mw-ref" id="cite_ref-McKee_88-0"><a href="#cite_note-McKee-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span> Lactic acidosis, a potentially life-threatening buildup of <a href="Lactic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Lactic_acid" title="Lactic acid">lactic acid</a> in the body, may also occur due to mitochondrial toxicity.<span class="mw-ref" id="cite_ref-Barnhill_86-1"><a href="#cite_note-Barnhill-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span> Because of these long-term effects, the manufacturer recommends weekly complete blood counts during linezolid therapy to monitor for possible bone marrow suppression, and recommends that treatment last no more than 28 days.<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-7"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-French_68-4"><a href="#cite_note-French-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> A more extensive monitoring protocol for early detection of toxicity in seriously ill patients receiving linezolid has been developed and proposed by a team of researchers in Melbourne, Australia. The protocol includes twice-weekly blood tests and liver function tests; measurement of serum <a href="Lactic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Lactic_acid" title="Lactic acid">lactate</a> levels, for early detection of lactic acidosis; a review of all medications taken by the patient, interrupting the use of those that may interact with linezolid; and periodic eye and neurological exams in patients set to receive linezolid for longer than four weeks.<span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span></p>

<p>The adverse effects of long-term linezolid therapy were first identified during postmarketing surveillance. Bone marrow suppression was not identified during Phase III trials, in which treatment did not exceed 21 days. Although some participants of early trials did experience thrombocytopenia, it was found to be reversible and did not occur significantly more frequently than in controls (participants not taking linezolid).<span class="mw-ref" id="cite_ref-Moellering_49-4"><a href="#cite_note-Moellering-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> There have also been postmarketing reports of seizures, and, <span>as of 2009</span>, a single case each of Bell's palsy (paralysis of the facial nerve) and kidney toxicity.<span class="mw-ref" id="cite_ref-Metaxas_69-3"><a href="#cite_note-Metaxas-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Evidence of protein synthesis inhibition in mammalian cells by linezolid has been published.<span class="mw-ref" id="cite_ref-90"><a href="#cite_note-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Linezolid is a weak, non-selective, reversible monoamine oxidase inhibitor (MAOI), and should not be used concomitantly with other MAOIs, large amounts of <a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">tyramine</a>-rich foods (such as pork, aged cheeses, alcoholic beverages, or smoked and pickled foods), or serotonergic drugs. There have been postmarketing reports of serotonin syndrome when linezolid was given with or soon after the discontinuation of serotonergic drugs, particularly selective serotonin reuptake inhibitors such as <a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">paroxetine</a> and <a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">sertraline</a>.<span class="mw-ref" id="cite_ref-French_68-5"><a href="#cite_note-French-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-91"><a href="#cite_note-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span><span class="mw-ref" id="cite_ref-Huang_92-0"><a href="#cite_note-Huang-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span><span class="mw-ref" id="cite_ref-93"><a href="#cite_note-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span> It may also enhance the blood pressure-increasing effects of sympathomimetic drugs such as <a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">pseudoephedrine</a> or <a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">phenylpropanolamine</a>.<span class="mw-ref" id="cite_ref-Moellering_49-5"><a href="#cite_note-Moellering-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-Stalker_94-0"><a href="#cite_note-Stalker-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> It should also not be given in combination with <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">pethidine</a> (<a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Meperidine" title="Meperidine" class="mw-redirect">meperidine</a>) under any circumstance due to the risk of serotonin syndrome.</p>

<p>Linezolid does not inhibit or induce the cytochrome P450 (CYP) system, which is responsible for the metabolism of many commonly used drugs, and therefore does not have any CYP-related interactions.<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-8"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    

<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Ribosome_mRNA_translation_en.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ribosome_mRNA_translation_en.svg.png" data-file-width="651" data-file-height="459" data-file-type="drawing" height="155" width="220"><div class="thumbcaption" style="text-align: left">Simplified schematic of mRNA translation. Linezolid occupies the A site (at center) and prevents tRNA from binding.</div></div></div>

<p>Linezolid, like other oxazolidinones, is a bacterial protein synthesis inhibitor and a weak, non-selective, reversible monoamine oxidase inhibitor.<span class="mw-ref" id="cite_ref-Roger2018_2-4"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Oxazolidinones_MAOI_2010_review_95-0"><a href="#cite_note-Oxazolidinones_MAOI_2010_review-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span> As a protein synthesis inhibitor, linezolid stops the growth and reproduction of bacteria by disrupting translation of messenger RNA (mRNA) into proteins in bacterial ribosomes.<span class="mw-ref" id="cite_ref-Roger2018_2-5"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Linezolid inhibits translation at the first step of protein synthesis, <i>initiation</i>,<span class="mw-ref" id="cite_ref-Roger2018_2-6"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Tedizolid_and_oxazolidinones_2015_review_96-0"><a href="#cite_note-Tedizolid_and_oxazolidinones_2015_review-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span> unlike most other protein synthesis inhibitors, which inhibit <i>elongation</i>.<span class="mw-ref" id="cite_ref-Swaney1998_8-2"><a href="#cite_note-Swaney1998-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-American_Family_Physician_57-1"><a href="#cite_note-American_Family_Physician-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> It does so by preventing the formation of the initiation complex, composed of the 30S and 50S subunits of the ribosome, tRNA, and mRNA. Linezolid binds to the 23S portion of the 50S subunit (the center of peptidyl transferase activity),<span class="mw-ref" id="cite_ref-Roger2018_2-7"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Tedizolid_and_oxazolidinones_2015_review_96-1"><a href="#cite_note-Tedizolid_and_oxazolidinones_2015_review-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span> close to the binding sites of <a href="Chloramphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloramphenicol" title="Chloramphenicol">chloramphenicol</a>, <a href="Lincomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lincomycin" title="Lincomycin">lincomycin</a>, and other antibiotics. Due to this unique mechanism of action, cross-resistance between linezolid and other protein synthesis inhibitors is highly infrequent or nonexistent.<span class="mw-ref" id="cite_ref-Herrmann_18-7"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-Moellering_49-6"><a href="#cite_note-Moellering-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p>

<p>In 2008, the crystal structure of linezolid bound to the 50S subunit of a ribosome from the archaean <i>Haloarcula marismortui</i> was elucidated by a team of scientists from Yale University and deposited in the Protein Data Bank.<span class="mw-ref" id="cite_ref-97"><a href="#cite_note-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span> Another team in 2008 determined the structure of linezolid bound to a 50S subunit of <i>Deinococcus radiodurans</i>. The authors proposed a refined model for the mechanism of action of oxazolidinones, finding that linezolid occupies the A site of the 50S ribosomal subunit, inducing a conformational change that prevents tRNA from entering the site and ultimately forcing tRNA to separate from the ribosome.<span class="mw-ref" id="cite_ref-98"><a href="#cite_note-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Linezolid_metabolism.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Linezolid_metabolism.svg.png" data-file-width="1207" data-file-height="810" data-file-type="drawing" height="148" width="220"><div class="thumbcaption" style="text-align: left">Major metabolites of linezolid</div></div></div>

<p>One of the advantages of linezolid is that it has an absolute oral bioavailability of 100% due to its rapid and complete absorption after oral administration;<span class="mw-ref" id="cite_ref-Roger2018_2-8"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> in other words, the entire dose reaches the bloodstream, as if it had been given intravenously.<span class="mw-ref" id="cite_ref-Roger2018_2-9"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> This means that people receiving intravenous linezolid may be switched to oral linezolid as soon as their condition allows it, whereas comparable antibiotics (such as vancomycin and quinupristin/dalfopristin) can only be given intravenously.<span class="mw-ref" id="cite_ref-Roger2018_2-10"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-American_Family_Physician_57-2"><a href="#cite_note-American_Family_Physician-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span>
Taking linezolid with food somewhat slows its absorption, but the area under the curve is not affected.<span class="mw-ref" id="cite_ref-Herrmann_18-8"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Linezolid's plasma protein binding is approximately 31% (range <span class="nowrap">4–32%</span>) and its volume of distribution at steady state averages <span class="nowrap">36.1–47.3</span><span>&nbsp;</span>liters in healthy adult volunteers.<span class="mw-ref" id="cite_ref-Roger2018_2-11"><a href="#cite_note-Roger2018-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Peak plasma concentrations (C<sub>max</sub>) are reached one to two hours after administration of the drug. Linezolid is readily distributed to all tissues in the body apart from bone matrix and white adipose tissue.<span class="mw-ref" id="cite_ref-Barbachyn_30-2"><a href="#cite_note-Barbachyn-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Notably, the concentration of linezolid in the epithelial lining fluid (ELF) of the lower respiratory tract is at least equal to, and often higher than, that achieved in serum (some authors have reported bronchial fluid concentrations up to four times higher than serum concentrations), which may account for its efficacy in treating pneumonia. However, a meta-analysis of clinical trials found that linezolid was not superior to <a href="Vancomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vancomycin" title="Vancomycin">vancomycin</a>, which achieves lower concentrations in the ELF.<span class="mw-ref" id="cite_ref-Kalil_et_al_99-0"><a href="#cite_note-Kalil_et_al-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span> Cerebrospinal fluid (CSF) concentrations vary; peak CSF concentrations are lower than serum ones, due to slow diffusion across the blood–brain barrier, and trough concentrations in the CSF are higher for the same reason.<span class="mw-ref" id="cite_ref-Herrmann_18-9"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> The average half-life is three hours in children, four hours in teenagers, and five hours in adults.<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-9"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Linezolid is metabolized in the liver, by oxidation of the <a href="Morpholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morpholine" title="Morpholine">morpholine</a> ring, without involvement of the cytochrome P450 system. This metabolic pathway leads to two major inactive metabolites (which each account for around 45% and 10% of an excreted dose at steady state), one minor metabolite, and several trace metabolites, none of which accounts for more than 1% of an excreted dose.<span class="mw-ref" id="cite_ref-Slatter_100-0"><a href="#cite_note-Slatter-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> Clearance of linezolid varies with age and gender; it is fastest in children (which accounts for the shorter half-life), and appears to be 20% lower in women than in men.<span class="mw-ref" id="cite_ref-Zyvox_FDA_label_4-10"><a href="#cite_note-Zyvox_FDA_label-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Slatter_100-1"><a href="#cite_note-Slatter-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span><span class="mw-ref" id="cite_ref-Sisson_101-0"><a href="#cite_note-Sisson-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> There is a strong correlation between linezolid clearance and creatinine clearance.<span class="mw-ref" id="cite_ref-Bialvaei_102-0"><a href="#cite_note-Bialvaei-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>At physiological pH (7.4), linezolid exists in an uncharged state. It is moderately water-soluble (approximately 3<span>&nbsp;</span>mg/mL), with a log<i>P</i> of 0.55.<span class="mw-ref" id="cite_ref-Herrmann_18-10"><a href="#cite_note-Herrmann-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Linezolid_showing_oxazolidinone_pharmacophore.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Linezolid_showing_oxazolidinone_pharmacophore.svg.png" data-file-width="1633" data-file-height="676" data-file-type="drawing" height="91" width="220"><div class="thumbcaption" style="text-align: left">Numbered structure of linezolid, showing the pharmacophore required for good activity (in blue) and desirable structural features (in orange).</div></div></div>
<p>The oxazolidinone pharmacophore—the chemical "template" essential for antimicrobial activity—consists of a <a href="2-Oxazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Oxazolidone" title="2-Oxazolidone">1,3-oxazolidin-2-one</a> moiety with an aryl group at position 3 and an <i>S</i>-<a href="Methyl_group.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyl_group" title="Methyl group">methyl group</a>, with another substituent attached to it, at position 5 (the <i>R</i>-enantiomers of all oxazolidinones are devoid of antibiotic properties).<span class="mw-ref" id="cite_ref-Brickner_103-0"><a href="#cite_note-Brickner-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> In addition to this essential core, linezolid also contains several structural characteristics that improve its effectiveness and safety. An <a href="Acetamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetamide" title="Acetamide">acetamide</a> substituent on the 5-methyl group is the best choice in terms of antibacterial efficacy, and is used in all of the more active oxazolidinones developed thus far; in fact, straying too far from an acetamide group at this position makes the drug lose its antimicrobial power, although weak to moderate activity is maintained when some isosteric groups are used. A <a href="Fluorine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorine" title="Fluorine">fluorine</a> atom at the 3′ position practically doubles <i>in vitro</i> and <i>in vivo</i> activity, and the electron-donating <a href="Nitrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrogen" title="Nitrogen">nitrogen</a> atom in the <a href="Morpholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morpholine" title="Morpholine">morpholine</a> ring helps maintain high antibiotic potency and an acceptable safety profile.<span class="mw-ref" id="cite_ref-Barbachyn_30-3"><a href="#cite_note-Barbachyn-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-Brickner_103-1"><a href="#cite_note-Brickner-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span></p>

<p>The anticoagulant rivaroxaban (Xarelto) bears a striking structural similarity to linezolid; both drugs share the oxazolidinone pharmacophore, differing in only three areas (an extra ketone and chloro<a href="Thiophene.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiophene" title="Thiophene">thiophene</a>, and missing the fluorine atom). However this similarity appears to carry no clinical significance.<span class="mw-ref" id="cite_ref-104"><a href="#cite_note-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Synthesis">Synthesis</h3></summary>
    
<p>Linezolid is a completely synthetic drug: it does not occur in nature (unlike erythromycin and many other antibiotics) and was not developed by building upon a naturally occurring skeleton (unlike most beta-lactams, which are semisynthetic). Many approaches are available for oxazolidinone synthesis, and several routes for the synthesis of linezolid have been reported in the chemistry literature.<span class="mw-ref" id="cite_ref-Brickner_103-2"><a href="#cite_note-Brickner-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span><span class="mw-ref" id="cite_ref-Xu_105-0"><a href="#cite_note-Xu-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span> Despite good yields, the original method (developed by Upjohn for pilot plant-scale production of linezolid and eperezolid) is lengthy, requires the use of expensive chemicals—such as palladium on carbon and the highly sensitive reagents <a href="Methanesulfonyl_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Methanesulfonyl_chloride" title="Methanesulfonyl chloride">methanesulfonyl chloride</a> and <a href="N-Butyllithium-1.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Butyllithium" title="N-Butyllithium"><i>n</i>-butyllithium</a>—and needs low-temperature conditions.<span class="mw-ref" id="cite_ref-Brickner_103-3"><a href="#cite_note-Brickner-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span><span class="mw-ref" id="cite_ref-Xu_105-1"><a href="#cite_note-Xu-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span><span class="mw-ref" id="cite_ref-Kaiser_106-0"><a href="#cite_note-Kaiser-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span> Much of the high cost of linezolid has been attributed to the expense of its synthesis.<span class="mw-ref" id="cite_ref-Kaiser_106-1"><a href="#cite_note-Kaiser-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span> A somewhat more concise and cost-effective route better suited to large-scale production was patented by Upjohn in 1998.<span class="mw-ref" id="cite_ref-Barbachyn_30-4"><a href="#cite_note-Barbachyn-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-107"><a href="#cite_note-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span></p>

<p>Later syntheses have included an "atom-economical" method starting from <a href="Mannitol.htm" tppabs="https://ptable.com/wiki/compounds/A/D-Mannitol" title="D-Mannitol" class="mw-redirect"><small>D</small>-mannitol</a>, developed by Indian pharmaceutical company Dr. Reddy's and reported in 1999,<span class="mw-ref" id="cite_ref-108"><a href="#cite_note-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span> and a route starting from (<i>S</i>)-glyceraldehyde acetonide (prepared from <a href="Vitamin_C.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_C" title="Vitamin C">vitamin C</a>), developed by a team of researchers from Hunan Normal University in Changsha, Hunan, China.<span class="mw-ref" id="cite_ref-Xu_105-2"><a href="#cite_note-Xu-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span>  On 25 June 2008, during the 12th Annual Green Chemistry and Engineering Conference in New York, Pfizer reported the development of their "second-generation" synthesis of linezolid: a convergent, green synthesis starting from (<i>S</i>)-<a href="Epichlorohydrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epichlorohydrin" title="Epichlorohydrin">epichlorohydrin</a>, with higher yield and a 56% reduction in total waste.<span class="mw-ref" id="cite_ref-109"><a href="#cite_note-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Resistance">Resistance</h2></summary>
    
<p>Acquired resistance to linezolid was reported as early as 1999, in two patients with severe, multidrug-resistant <i>Enterococcus faecium</i> infection who received the drug through a compassionate use program.<span class="mw-ref" id="cite_ref-DrugTherPerspect_64-3"><a href="#cite_note-DrugTherPerspect-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> Linezolid-resistant <i>Staphylococcus aureus</i> was first isolated in 2001.<span class="mw-ref" id="cite_ref-110"><a href="#cite_note-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span></p>

<p>In the United States, resistance to linezolid has been monitored and tracked since 2004 through a program named LEADER, which (<span>as of 2007</span>) was conducted in 60 medical institutions throughout the country. Resistance has remained stable and extremely low—less than one-half of one percent of <a href="javascript:if(confirm('https://en.wiktionary.org/wiki/isolate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wiktionary.org/wiki/isolate'" tppabs="https://en.wiktionary.org/wiki/isolate" title="wikt:isolate" class="external">isolates</a> overall, and less than one-tenth of one percent of <i>S. aureus</i> samples.<span class="mw-ref" id="cite_ref-autogenerated1_111-0"><a href="#cite_note-autogenerated1-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span> A similar, worldwide program—the "Zyvox Annual Appraisal of Potency and Spectrum Study", or ZAAPS—has been conducted since 2002. <span>As of 2007</span>, overall resistance to linezolid in 23 countries was less than 0.2%, and nonexistent among streptococci. Resistance was only found in Brazil, China, Ireland, and Italy, among coagulase-negative staphylococci (0.28% of samples resistant), enterococci (0.11%), and <i>S. aureus</i> (0.03%).<span class="mw-ref" id="cite_ref-ZAAPS2007_112-0"><a href="#cite_note-ZAAPS2007-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span> In the United Kingdom and Ireland, no resistance was found in staphylococci collected from bacteremia cases between 2001 and 2006,<span class="mw-ref" id="cite_ref-113"><a href="#cite_note-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span> although resistance in enterococci has been reported.<span class="mw-ref" id="cite_ref-114"><a href="#cite_note-114" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span> Some authors have predicted that resistance in <i>E. faecium</i> will increase if linezolid use continues at current levels or increases.<span class="mw-ref" id="cite_ref-Scheetz_115-0"><a href="#cite_note-Scheetz-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span> Nevertheless, linezolid continues to be an important antimicrobial agent with near-complete activity (0.05% resistance).<span class="mw-ref" id="cite_ref-Bialvaei_102-1"><a href="#cite_note-Bialvaei-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism">Mechanism</h3></summary>
    
<p>The <i>intrinsic</i> resistance of most Gram-negative bacteria to linezolid is due to the activity of efflux pumps, which actively "pump" linezolid out of the cell faster than it can accumulate.<span class="mw-ref" id="cite_ref-Barbachyn_30-5"><a href="#cite_note-Barbachyn-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-116"><a href="#cite_note-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span></p>

<p>Gram-positive bacteria usually develop resistance to linezolid as the result of a point mutation known as <i>G2576T</i>, in which a <a href="Guanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanine" title="Guanine">guanine</a> base is replaced with <a href="Thymine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thymine" title="Thymine">thymine</a> in base pair 2576 of the genes coding for 23S ribosomal RNA.<span class="mw-ref" id="cite_ref-Saager_117-0"><a href="#cite_note-Saager-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span><span class="mw-ref" id="cite_ref-Besier_118-0"><a href="#cite_note-Besier-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span> This is the most common mechanism of resistance in staphylococci, and the only one known to date in isolates of <i>E. faecium</i>.<span class="mw-ref" id="cite_ref-Scheetz_115-1"><a href="#cite_note-Scheetz-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span> Other mechanisms have been identified in <i>Streptococcus pneumoniae</i> (including mutations in an RNA methyltransferase that methylates G2445 of the 23S rRNA and mutations causing increased expression of ABC transporter genes)<span class="mw-ref" id="cite_ref-Feng2009_119-0"><a href="#cite_note-Feng2009-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> and in <i>Staphylococcus epidermidis</i>.<span class="mw-ref" id="cite_ref-120"><a href="#cite_note-120" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span><span class="mw-ref" id="cite_ref-121"><a href="#cite_note-121" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>The <a href="2-Oxazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Oxazolidone" title="2-Oxazolidone">oxazolidinones</a> have been known as monoamine oxidase inhibitors since the late 1950s. Their antimicrobial properties were discovered by researchers at E.I. duPont de Nemours in the 1970s.<span class="mw-ref" id="cite_ref-Brickner_103-4"><a href="#cite_note-Brickner-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> In 1978, DuPont patented a series of oxazolidinone derivatives as being effective in the treatment of bacterial and fungal plant diseases, and in 1984, another patent described their usefulness in treating bacterial infections in mammals.<span class="mw-ref" id="cite_ref-Moellering_49-7"><a href="#cite_note-Moellering-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-Brickner_103-5"><a href="#cite_note-Brickner-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> In 1987, DuPont scientists presented a detailed description of the oxazolidinones as a new class of antibiotics with a novel mechanism of action.<span class="mw-ref" id="cite_ref-Brickner_103-6"><a href="#cite_note-Brickner-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span><span class="mw-ref" id="cite_ref-Slee_122-0"><a href="#cite_note-Slee-122" style="counter-reset: mw-Ref 122;"><span class="mw-reflink-text">[122]</span></a></span> Early compounds were found to produce liver toxicity, however, and development was discontinued.<span class="mw-ref" id="cite_ref-Livermore_67-1"><a href="#cite_note-Livermore-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span></p>

<p>Pharmacia &amp; Upjohn (now part of Pfizer) started its own oxazolidinone research program in the 1990s. Studies of the compounds' structure–activity relationships led to the development of several subclasses of oxazolidinone derivatives, with varying safety profiles and antimicrobial activity. Two compounds were considered drug candidates: eperezolid (codenamed <i>PNU-100592</i>) and linezolid (<i>PNU-100766</i>).<span class="mw-ref" id="cite_ref-Barbachyn_30-6"><a href="#cite_note-Barbachyn-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-French_68-6"><a href="#cite_note-French-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> In the preclinical stages of development, they were similar in safety and antibacterial activity, so they were taken to Phase I clinical trials to identify any difference in pharmacokinetics.<span class="mw-ref" id="cite_ref-Livermore_67-2"><a href="#cite_note-Livermore-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-Ford_123-0"><a href="#cite_note-Ford-123" style="counter-reset: mw-Ref 123;"><span class="mw-reflink-text">[123]</span></a></span> Linezolid was found to have a pharmacokinetic advantage—requiring only twice-daily dosage, while eperezolid needed to be given three times a day to achieve similar exposure—and therefore proceeded to further trials.<span class="mw-ref" id="cite_ref-Barbachyn_30-7"><a href="#cite_note-Barbachyn-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> The U.S. Food and Drug Administration (FDA) approved linezolid on 18 April 2000.<span class="mw-ref" id="cite_ref-124"><a href="#cite_note-124" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span> Approval followed in Brazil (June 2000),<span class="mw-ref" id="cite_ref-125"><a href="#cite_note-125" style="counter-reset: mw-Ref 125;"><span class="mw-reflink-text">[125]</span></a></span> the United Kingdom (January 2001),<span class="mw-ref" id="cite_ref-SPC_17-1"><a href="#cite_note-SPC-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-French_68-7"><a href="#cite_note-French-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> Japan and Canada (April 2001),<span class="mw-ref" id="cite_ref-126"><a href="#cite_note-126" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span><span class="mw-ref" id="cite_ref-CanadaApproval_127-0"><a href="#cite_note-CanadaApproval-127" style="counter-reset: mw-Ref 127;"><span class="mw-reflink-text">[127]</span></a></span><span class="mw-ref" id="cite_ref-128"><a href="#cite_note-128" style="counter-reset: mw-Ref 128;"><span class="mw-reflink-text">[128]</span></a></span> Europe (throughout 2001),<span class="mw-ref" id="cite_ref-129"><a href="#cite_note-129" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span> and other countries in Latin America and Asia.<span class="mw-ref" id="cite_ref-CanadaApproval_127-1"><a href="#cite_note-CanadaApproval-127" style="counter-reset: mw-Ref 127;"><span class="mw-reflink-text">[127]</span></a></span></p>

<p><span>As of 2009</span>, linezolid was the only oxazolidinone antibiotic available.<span class="mw-ref" id="cite_ref-Livermore2009_130-0"><a href="#cite_note-Livermore2009-130" style="counter-reset: mw-Ref 130;"><span class="mw-reflink-text">[130]</span></a></span> Other members of this class have entered development, such as posizolid (AZD2563),<span class="mw-ref" id="cite_ref-131"><a href="#cite_note-131" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span> ranbezolid (RBx 7644),<span class="mw-ref" id="cite_ref-132"><a href="#cite_note-132" style="counter-reset: mw-Ref 132;"><span class="mw-reflink-text">[132]</span></a></span> and radezolid (RX-1741).<span class="mw-ref" id="cite_ref-133"><a href="#cite_note-133" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span> In 2014, the FDA approved tedizolid phosphate, a second-generation oxazolidinone derivative, for acute bacterial skin and skin structure infection.<span class="mw-ref" id="cite_ref-134"><a href="#cite_note-134" style="counter-reset: mw-Ref 134;"><span class="mw-reflink-text">[134]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Economics">Economics</h3></summary>
    


<p>Linezolid was quite expensive in 2009; a course of treatment may cost one or two thousand U.S. dollars for the drug alone,<span class="mw-ref" id="cite_ref-Lexi-Comp_59-6"><a href="#cite_note-Lexi-Comp-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> not to mention other costs (such as those associated with hospital stay). With the medication becoming generic the price has decreased such that in United States the wholesale cost of a course of treatment as of 2016 is about US$137.90.<span class="mw-ref" id="cite_ref-Medi2016_135-0"><a href="#cite_note-Medi2016-135" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span> In India as of 2015 a month of linezolid, as would be used to treat tuberculosis cost about US$60.<span class="mw-ref" id="cite_ref-WHO2015Use_5-1"><a href="#cite_note-WHO2015Use-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>

<p>However, because intravenous linezolid may be switched to an oral formulation (tablets or oral solution) without jeopardizing efficacy, people may be discharged from hospital relatively early and continue treatment at home, whereas home treatment with injectable antibiotics may be impractical.<span class="mw-ref" id="cite_ref-Grau2008_13-1"><a href="#cite_note-Grau2008-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Reducing the length of hospital stay reduces the overall cost of treatment, even though linezolid may have a higher acquisition cost—that is, it may be more expensive—than comparable antibiotics.</p>

<p>Studies have been conducted in several countries with different health care system models to assess the cost-effectiveness of linezolid compared to glycopeptides such as vancomycin or teicoplanin. In most countries, linezolid was more cost-effective than comparable antibiotics for the treatment of hospital-acquired pneumonia and complicated skin and skin structure infections, either due to higher cure and survival rates or lower overall treatment costs.<span class="mw-ref" id="cite_ref-Grau2008_13-2"><a href="#cite_note-Grau2008-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>In 2009, Pfizer paid $2.3<span>&nbsp;</span>billion and entered a corporate integrity agreement to settle charges that it had misbranded and illegally promoted four drugs, and caused false claims to be submitted to government healthcare programs for uses that had not been approved by the United States Food and Drug Administration.<span class="mw-ref" id="cite_ref-136"><a href="#cite_note-136" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span> $1.3<span>&nbsp;</span>billion was paid to settle criminal charges of illegally marketing the anti-inflammatory <a href="Valdecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Valdecoxib" title="Valdecoxib">valdecoxib</a>, while $1<span>&nbsp;</span>billion was paid in civil fines regarding illegal marketing of three other drugs, including Zyvox.<span class="mw-ref" id="cite_ref-137"><a href="#cite_note-137" style="counter-reset: mw-Ref 137;"><span class="mw-reflink-text">[137]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<table class="wikitable mw-collapsible mw-collapsed" style="width:100%">
<caption>List of trade names for linezolid<span class="mw-ref" id="cite_ref-Name2018Int_138-0"><a href="#cite_note-Name2018Int-138" style="counter-reset: mw-Ref 138;"><span class="mw-reflink-text">[138]</span></a></span></caption>
<tbody><tr>
<td>A</td><td>Amizole 500 (Kenya), Anozilad (Poland), Antizolid (Greece), Arlid (India), Arlin (Bangladesh), Averozolid &amp; Debacozoline (Egypt)</td></tr>
<tr class="mw-empty-elt"></tr>
<tr>
<td>B</td><td></td></tr>
<tr>
<td>C</td><td></td></tr>
<tr>
<td>D</td><td>Dilizolen (Poland, Slovakia, Netherlands, Bulgaria)</td></tr>
<tr>
<td>E</td><td>Entavar (India)</td></tr>
<tr>
<td>F</td><td></td></tr>
<tr>
<td>G</td><td>Grampolid (Netherlands), Grampolyve (Netherlands), Gramposimide (Poland, Netherlands), Grampoxid (Netherlands)</td></tr>
<tr>
<td>H</td><td></td></tr>
<tr>
<td>I</td><td></td></tr>
<tr>
<td>J</td><td></td></tr>
<tr>
<td>K</td><td></td></tr>
<tr>
<td>L</td><td>Lidobact (Netherlands), Linez (Bangladesh, Egypt), Linezolid Accord (Netherlands), Linezolid Amneal (Netherlands), Linezolid Betapharm (Netherlands), Linezolid Farmaprojects (Netherlands), Linezolid Fresenius Kabi (Netherlands), Linezolid GNP (Egypt), Linezolid Hetero (Netherlands), Linezolid Kabi (Croatia, Poland), Linezolid Mylan (Netherlands), Linezolid Pfizer (Netherlands), Linezolid Pliva (Croatia), Linezolid Polpharma (Netherlands, Poland), Linezolid Richet (Argentina), Linezolid Sandoz (Belgium, Switzerland, Netherlands, Slovakia, Estonia, Croatia, Poland), Linezolid Teva (Netherlands, Romania), Linezolid Zentiva (Poland), Linezolida Teva (Portugal), Linezone (Turkey), Linid (India), Linosept (India), Linozid (Bangladesh), Linxyd (Netherlands), Linzolid (Bangladesh), Linzowin (India), Litrecan (Argentina), Livegramide (Netherlands), Lizbid (India), Lizemox (India), Lizolid (India, Vietnam), Lizoliden (Netherlands), Lizomac (India), Lizomed (India), Lizorex (India), Lizox (Netherlands), Lorezogram (Netherlands), Lynvox (Netherlands), Lynz (Croatia)</td></tr>
<tr>
<td>M</td><td></td></tr>
<tr>
<td>N</td><td>Natlinez (Netherlands)</td></tr>
<tr>
<td>O</td><td></td></tr>
<tr>
<td>P</td><td>Pneumolid (Croatia, Netherlands, Poland, Romania, Bulgaria)</td></tr>
<tr>
<td>Q</td><td></td></tr>
<tr>
<td>R</td><td>Ralinz (India), Respenzo (Egypt)</td></tr>
<tr>
<td>S</td><td>Synzolid (Netherlands)</td></tr>
<tr>
<td>T</td><td></td></tr>
<tr>
<td>U</td><td></td></tr>
<tr>
<td>V</td><td>Voxazoldin (Egypt)</td></tr>
<tr>
<td>W</td><td></td></tr>
<tr>
<td>X</td><td></td></tr>
<tr>
<td>Y</td><td></td></tr>
<tr>
<td>Z</td><td>Zenix (Bosnia, Herzegowina, Serbia), Zizolid (Turkey), Zodlin (India), Zolinid (Bulgaria), Zyvox (Georgia, Chile, Argentina, Australia, China, Ecuador, Egypt, United Kingdom, Hong Kong, Indonesia, Ireland, South Korea, Malta, Malaysia, New Zealand, Philippines, Singapore, Thailand, Taiwan, Japan, United States), Zyvoxam (Canada), Zyvoxid (Israel, Austria, Belgium, Bulgaria, Switzerland, Czech Republic, Denmark, Estonia, Spain, Finland, France, Greece, Germany, Croatia, Iceland, Lithuania, Latvia, Netherlands, Norway, Portugal, Romania, Sweden, Slovakia, Tunisia, Turkey, South Africa, Poland, Italy, Bosnia, Herzegowina)</td></tr>
<tr class="mw-empty-elt"></tr>
</tbody></table>
<table class="wikitable mw-collapsible mw-collapsed" style="width:100%">
<caption>List of trade names for linezolid-containing products<span class="mw-ref" id="cite_ref-Name2018Int_138-1"><a href="#cite_note-Name2018Int-138" style="counter-reset: mw-Ref 138;"><span class="mw-reflink-text">[138]</span></a></span></caption>
<tbody><tr>
<th scope="col">Generic Combination</th>
<th scope="col">Brand Name</th></tr>
<tr>
<td>linezolid and cefixime</td><td>Zifi-Turbo (India)</td></tr>
</tbody></table>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/linezolid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/linezolid.html'" tppabs="https://www.drugs.com/pregnancy/linezolid.html" class="external text external">"Linezolid (Zyvox) Use During Pregnancy"</a>. <i>Drugs.com</i>. 16 April 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">17 March</span> 2020</span>.</cite></span></li><li id="cite_note-Roger2018-2"> <span id="mw-reference-text-cite_note-Roger2018-2" class="mw-reference-text"><cite id="CITEREFRogerRobertsMuller2018" class="citation journal cs1">Roger C, Roberts JA, Muller L (May 2018). "Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones". <i>Clinical Pharmacokinetics</i>. <b>57</b> (5): 559–575. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40262-017-0601-x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40262-017-0601-x'" tppabs="https://doi.org/10.1007%2Fs40262-017-0601-x" class="external text external">10.1007/s40262-017-0601-x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29063519  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29063519'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29063519" class="external text external">29063519</a>.</cite></span></li><li id="cite_note-AHFS2016-3"> <span id="mw-reference-text-cite_note-AHFS2016-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/linezolid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/linezolid.html'" tppabs="https://www.drugs.com/monograph/linezolid.html" class="external text external">"Linezolid"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20161220231329/https://www.drugs.com/monograph/linezolid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161220231329/https://www.drugs.com/monograph/linezolid.html'" tppabs="https://web.archive.org/web/20161220231329/https://www.drugs.com/monograph/linezolid.html" class="external text external">Archived</a> from the original on 20 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">8 December</span> 2016</span>.</cite></span></li><li id="cite_note-Zyvox_FDA_label-4"> <span id="mw-reference-text-cite_note-Zyvox_FDA_label-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd" class="external text external">"Zyvox- linezolid injection, solution Zyvox- linezolid tablet, film coated Zyvox- linezolid suspension"</a>. <i>DailyMed</i>. 21 February 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">17 March</span> 2020</span>.</cite></span></li><li id="cite_note-WHO2015Use-5"> <span id="mw-reference-text-cite_note-WHO2015Use-5" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2015" class="citation book cs1">World Health Organization (2015). <i>The selection and use of essential medicines. Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children)</i>. Geneva: World Health Organization. pp.<span>&nbsp;</span>26–33. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F189763  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F189763'" tppabs="https://hdl.handle.net/10665%2F189763" class="external text external">10665/189763</a></span>. ISBN<span>&nbsp;</span><bdi>9789241209946</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0512-3054  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0512-3054'" tppabs="https://www.worldcat.org/issn/0512-3054" class="external text external">0512-3054</a>. WHO technical report series;994.</cite></span></li><li id="cite_note-Marino2007-6"> <span id="mw-reference-text-cite_note-Marino2007-6" class="mw-reference-text"><cite id="CITEREFMarinoSutin2007" class="citation book cs1">Marino PL, Sutin KM (2007). "Antimicrobial therapy". <i>The ICU book</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. p.<span>&nbsp;</span>817. ISBN<span>&nbsp;</span><bdi>978-0-7817-4802-5</bdi>.</cite></span></li><li id="cite_note-SFX2016-7"> <span id="mw-reference-text-cite_note-SFX2016-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/sfx/linezolid-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/sfx/linezolid-side-effects.html'" tppabs="https://www.drugs.com/sfx/linezolid-side-effects.html" class="external text external">"Linezolid Side Effects in Detail"</a>. <i>drugs.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161220233415/https://www.drugs.com/sfx/linezolid-side-effects.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161220233415/https://www.drugs.com/sfx/linezolid-side-effects.html'" tppabs="https://web.archive.org/web/20161220233415/https://www.drugs.com/sfx/linezolid-side-effects.html" class="external text external">Archived</a> from the original on 20 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">11 December</span> 2016</span>.</cite></span></li><li id="cite_note-Swaney1998-8"> <span id="mw-reference-text-cite_note-Swaney1998-8" class="mw-reference-text"><cite id="CITEREFSwaneyAokiGanozaShinabarger1998" class="citation journal cs1">Swaney SM, Aoki H, Ganoza MC, Shinabarger DL (December 1998). <a href="javascript:if(confirm('http://aac.asm.org/cgi/reprint/42/12/3251.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://aac.asm.org/cgi/reprint/42/12/3251.pdf'" tppabs="http://aac.asm.org/cgi/reprint/42/12/3251.pdf" class="external text external">"The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria"</a> <span class="cs1-format">(PDF)</span>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>42</b> (12): 3251–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.42.12.3251  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.42.12.3251'" tppabs="https://doi.org/10.1128%2FAAC.42.12.3251" class="external text external">10.1128/AAC.42.12.3251</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106030'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106030" class="external text external">106030</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9835522  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9835522'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9835522" class="external text external">9835522</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFMendesDeshpandeJones2014" class="citation journal cs1">Mendes RE, Deshpande LM, Jones RN (April 2014). "Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms". <i>Drug Resistance Updates</i>. <b>17</b> (1–2): 1–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.drup.2014.04.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.drup.2014.04.002'" tppabs="https://doi.org/10.1016%2Fj.drup.2014.04.002" class="external text external">10.1016/j.drup.2014.04.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24880801  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24880801'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24880801" class="external text external">24880801</a>. <q>Emergence of resistance has been limited<span>&nbsp;</span>... It is still uncertain whether the occurrences of such isolates are becoming more prevalent.</q></cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFLiCorey2013" class="citation book cs1">Li JJ, Corey EJ (2013). <a href="javascript:if(confirm('https://books.google.com/books?id=mIyxO5cLEAcC&pg=PA6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=mIyxO5cLEAcC&pg=PA6'" tppabs="https://books.google.com/books?id=mIyxO5cLEAcC&pg=PA6" class="external text external"><i>Drug Discovery: Practices, Processes, and Perspectives</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>6. ISBN<span>&nbsp;</span><bdi>978-1-118-35446-9</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172617/https://books.google.com/books?id=mIyxO5cLEAcC&pg=PA6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172617/https://books.google.com/books?id=mIyxO5cLEAcC&pg=PA6'" tppabs="https://web.archive.org/web/20170910172617/https://books.google.com/books?id=mIyxO5cLEAcC&pg=PA6" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFTorokMoranCooke2009" class="citation book cs1">Torok E, Moran E, Cooke F (2009). <a href="javascript:if(confirm('https://books.google.com/books?id=5W-WBQAAQBAJ&pg=PT56  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5W-WBQAAQBAJ&pg=PT56'" tppabs="https://books.google.com/books?id=5W-WBQAAQBAJ&pg=PT56" class="external text external">"Chapter 2 Antimicrobials"</a>. <i>Oxford Handbook of Infectious Diseases and Microbiology</i>. OUP Oxford. ISBN<span>&nbsp;</span><bdi>978-0-19-103962-1</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908143257/https://books.google.com/books?id=5W-WBQAAQBAJ&pg=PT56  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908143257/https://books.google.com/books?id=5W-WBQAAQBAJ&pg=PT56'" tppabs="https://web.archive.org/web/20170908143257/https://books.google.com/books?id=5W-WBQAAQBAJ&pg=PT56" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-WHO21st-12"> <span id="mw-reference-text-cite_note-WHO21st-12" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-Grau2008-13"> <span id="mw-reference-text-cite_note-Grau2008-13" class="mw-reference-text"><cite id="CITEREFGrauRubio-Terrés2008" class="citation journal cs1">Grau S, Rubio-Terrés C (April 2008). "Pharmacoeconomics of linezolid". <i>Expert Opinion on Pharmacotherapy</i>. <b>9</b> (6): 987–1000. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.9.6.987  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.9.6.987'" tppabs="https://doi.org/10.1517%2F14656566.9.6.987" class="external text external">10.1517/14656566.9.6.987</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18377341  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18377341'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18377341" class="external text external">18377341</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFWroe2002" class="citation news cs1">Wroe D (28 February 2002). <a href="javascript:if(confirm('http://www.theage.com.au/articles/2002/02/27/1014704966995.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.theage.com.au/articles/2002/02/27/1014704966995.html'" tppabs="http://www.theage.com.au/articles/2002/02/27/1014704966995.html" class="external text external">"An antibiotic to fight immune bugs"</a>. <i>The Age</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20100127140624/http://www.theage.com.au/articles/2002/02/27/1014704966995.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100127140624/http://www.theage.com.au/articles/2002/02/27/1014704966995.html'" tppabs="https://web.archive.org/web/20100127140624/http://www.theage.com.au/articles/2002/02/27/1014704966995.html" class="external text external">Archived</a> from the original on 27 January 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">16 May</span> 2009</span>.</cite></span></li><li id="cite_note-Wilson-15"> <span id="mw-reference-text-cite_note-Wilson-15" class="mw-reference-text"><cite id="CITEREFWilsonCepedaHaymanWhitehouse2006" class="citation journal cs1">Wilson AP, Cepeda JA, Hayman S, Whitehouse T, Singer M, Bellingan G (August 2006). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkl233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkl233'" tppabs="https://doi.org/10.1093/jac/dkl233" class="external text external">"In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients"</a>. <i>The Journal of Antimicrobial Chemotherapy</i>. <b>58</b> (2): 470–3. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkl233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkl233'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkl233" class="external text external">10.1093/jac/dkl233</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16735420  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16735420'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16735420" class="external text external">16735420</a>.</cite></span></li><li id="cite_note-Bozdogan-16"> <span id="mw-reference-text-cite_note-Bozdogan-16" class="mw-reference-text"><cite id="CITEREFBozdoganAppelbaum2004" class="citation journal cs1">Bozdogan B, Appelbaum PC (February 2004). "Oxazolidinones: activity, mode of action, and mechanism of resistance". <i>International Journal of Antimicrobial Agents</i>. <b>23</b> (2): 113–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijantimicag.2003.11.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijantimicag.2003.11.003'" tppabs="https://doi.org/10.1016%2Fj.ijantimicag.2003.11.003" class="external text external">10.1016/j.ijantimicag.2003.11.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15013035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15013035'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15013035" class="external text external">15013035</a>.</cite></span></li><li id="cite_note-SPC-17"> <span id="mw-reference-text-cite_note-SPC-17" class="mw-reference-text"><cite id="CITEREF[No_authors_listed]2009" class="citation web cs1">[No authors listed] (24 June 2009). <a href="javascript:if(confirm('https://www.webcitation.org/68IbE5SXR?url=http://www.medicines.org.uk/emc/medicine/9857  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.webcitation.org/68IbE5SXR?url=http://www.medicines.org.uk/emc/medicine/9857'" tppabs="https://www.webcitation.org/68IbE5SXR?url=http://www.medicines.org.uk/emc/medicine/9857" class="external text external">"Zyvox 600 mg Film-Coated Tablets, 100 mg/5 ml Granules for Oral Suspension, 2 mg/ml Solution for Infusion<span>&nbsp;</span>– Summary of Product Characteristics (SPC)"</a>. electronic Medicines Compendium. Archived from <a href="javascript:if(confirm('http://emc.medicines.org.uk/medicine/9857  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://emc.medicines.org.uk/medicine/9857'" tppabs="http://emc.medicines.org.uk/medicine/9857" class="external text external">the original</a> on 9 June 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">3 July</span> 2009</span>.</cite></span></li><li id="cite_note-Herrmann-18"> <span id="mw-reference-text-cite_note-Herrmann-18" class="mw-reference-text"><cite id="CITEREFHerrmannPeppardLedeboerTheesfeld2008" class="citation journal cs1">Herrmann DJ, Peppard WJ, Ledeboer NA, Theesfeld ML, Weigelt JA, Buechel BJ (December 2008). "Linezolid for the treatment of drug-resistant infections". <i>Expert Review of Anti-infective Therapy</i>. <b>6</b> (6): 825–48. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F14787210.6.6.825  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F14787210.6.6.825'" tppabs="https://doi.org/10.1586%2F14787210.6.6.825" class="external text external">10.1586/14787210.6.6.825</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1478-7210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1478-7210'" tppabs="https://www.worldcat.org/issn/1478-7210" class="external text external">1478-7210</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19053895  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19053895'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19053895" class="external text external">19053895</a>.</cite></span></li><li id="cite_note-Falagas2008-19"> <span id="mw-reference-text-cite_note-Falagas2008-19" class="mw-reference-text"><cite id="CITEREFFalagasSiemposVardakas2008" class="citation journal cs1">Falagas ME, Siempos II, Vardakas KZ (January 2008). "Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials". <i>Lancet Infectious Diseases</i>. <b>8</b> (1): 53–66. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1473-3099%2807%2970312-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1473-3099%2807%2970312-2'" tppabs="https://doi.org/10.1016%2FS1473-3099%2807%2970312-2" class="external text external">10.1016/S1473-3099(07)70312-2</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1473-3099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1473-3099'" tppabs="https://www.worldcat.org/issn/1473-3099" class="external text external">1473-3099</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18156089  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18156089'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18156089" class="external text external">18156089</a>.</cite> Structured abstract with quality assessment available at <a href="javascript:if(confirm('http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12008005415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12008005415'" tppabs="http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12008005415" class="external text external">DARE</a> <a href="javascript:if(confirm('https://web.archive.org/web/20111004094022/http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12008005415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20111004094022/http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12008005415'" tppabs="https://web.archive.org/web/20111004094022/http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12008005415" class="external text external">Archived</a><span> 4 October 2011 at the </span>Wayback Machine.</span></li><li id="cite_note-Tascini-20"> <span id="mw-reference-text-cite_note-Tascini-20" class="mw-reference-text"><cite id="CITEREFTasciniGemignaniDoria2009" class="citation journal cs1">Tascini C, Gemignani G, Doria R,  et al. (June 2009). "Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin". <i>Journal of Chemotherapy</i>. <b>21</b> (3): 311–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1179%2Fjoc.2009.21.3.311  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1179%2Fjoc.2009.21.3.311'" tppabs="https://doi.org/10.1179%2Fjoc.2009.21.3.311" class="external text external">10.1179/joc.2009.21.3.311</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1120-009X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1120-009X'" tppabs="https://www.worldcat.org/issn/1120-009X" class="external text external">1120-009X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19567352  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19567352'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19567352" class="external text external">19567352</a>.</cite></span></li><li id="cite_note-Chow-21"> <span id="mw-reference-text-cite_note-Chow-21" class="mw-reference-text"><cite id="CITEREFChowLemosEinarson2008" class="citation journal cs1">Chow I, Lemos EV, Einarson TR (2008). "Management and prevention of diabetic foot ulcers and infections: a health economic review". <i>PharmacoEconomics</i>. <b>26</b> (12): 1019–35. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F0019053-200826120-00005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F0019053-200826120-00005'" tppabs="https://doi.org/10.2165%2F0019053-200826120-00005" class="external text external">10.2165/0019053-200826120-00005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19014203  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19014203'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19014203" class="external text external">19014203</a>.</cite></span></li><li id="cite_note-Lipsky-22"> <span id="mw-reference-text-cite_note-Lipsky-22" class="mw-reference-text"><cite id="CITEREFLipskyItaniNorden2004" class="citation journal cs1">Lipsky BA, Itani K, Norden C (January 2004). <a href="javascript:if(confirm('https://doi.org/10.1086/380449  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/380449'" tppabs="https://doi.org/10.1086/380449" class="external text external">"Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate"</a>. <i>Clinical Infectious Diseases</i>. <b>38</b> (1): 17–24. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F380449  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F380449'" tppabs="https://doi.org/10.1086%2F380449" class="external text external">10.1086/380449</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14679443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14679443'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14679443" class="external text external">14679443</a>.</cite></span></li><li id="cite_note-Pigrau-23"> <span id="mw-reference-text-cite_note-Pigrau-23" class="mw-reference-text"><cite id="CITEREFPigrauAlmirante2009" class="citation journal cs1">Pigrau C, Almirante B (April 2009). <a href="javascript:if(confirm('https://web.archive.org/web/20110723082633/http://www.elsevier.es/sites/default/files/elsevier/pdf/28/28v27n04a13136682pdf001.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110723082633/http://www.elsevier.es/sites/default/files/elsevier/pdf/28/28v27n04a13136682pdf001.pdf'" tppabs="https://web.archive.org/web/20110723082633/http://www.elsevier.es/sites/default/files/elsevier/pdf/28/28v27n04a13136682pdf001.pdf" class="external text external">"<span>[</span>Oxazolidinones, glycopeptides and cyclic lipopeptides<span>]</span>"</a> <span>[</span>Oxazolidinones, glycopeptides and cyclic lipopeptides<span>]</span> <span class="cs1-format">(PDF)</span>. <i>Enfermedades Infecciosas y Microbiologia Clinica</i> (in Spanish). <b>27</b> (4): 236–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.eimc.2009.02.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.eimc.2009.02.004'" tppabs="https://doi.org/10.1016%2Fj.eimc.2009.02.004" class="external text external">10.1016/j.eimc.2009.02.004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19406516  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19406516'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19406516" class="external text external">19406516</a>. Archived from <a href="javascript:if(confirm('http://www.elsevier.es/sites/default/files/elsevier/pdf/28/28v27n04a13136682pdf001.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.elsevier.es/sites/default/files/elsevier/pdf/28/28v27n04a13136682pdf001.pdf'" tppabs="http://www.elsevier.es/sites/default/files/elsevier/pdf/28/28v27n04a13136682pdf001.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 23 July 2011.</cite></span></li><li id="cite_note-Vardakas-24"> <span id="mw-reference-text-cite_note-Vardakas-24" class="mw-reference-text"><cite id="CITEREFVardakasHorianopoulouFalagas2008" class="citation journal cs1">Vardakas KZ, Horianopoulou M, Falagas ME (June 2008). "Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials". <i>Diabetes Research and Clinical Practice</i>. <b>80</b> (3): 344–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.diabres.2008.01.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.diabres.2008.01.009'" tppabs="https://doi.org/10.1016%2Fj.diabres.2008.01.009" class="external text external">10.1016/j.diabres.2008.01.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18291550  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18291550'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18291550" class="external text external">18291550</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFGrammatikosFalagas2008" class="citation journal cs1">Grammatikos A, Falagas ME (2008). "Linezolid for the treatment of skin and soft tissue infection". <i>Expert Review of Dermatology</i>. <b>3</b> (5): 539–48. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F17469872.3.5.539  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F17469872.3.5.539'" tppabs="https://doi.org/10.1586%2F17469872.3.5.539" class="external text external">10.1586/17469872.3.5.539</a>.</cite></span></li><li id="cite_note-USCAPGuidelines-26"> <span id="mw-reference-text-cite_note-USCAPGuidelines-26" class="mw-reference-text"><cite id="CITEREFMandellWunderinkAnzueto2007" class="citation journal cs1">Mandell LA, Wunderink RG, Anzueto A,  et al. (March 2007). <a href="javascript:if(confirm('https://doi.org/10.1086/511159  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/511159'" tppabs="https://doi.org/10.1086/511159" class="external text external">"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults"</a>. <i>Clinical Infectious Diseases</i>. <b>44</b> (Suppl 2): S27–72. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F511159  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F511159'" tppabs="https://doi.org/10.1086%2F511159" class="external text external">10.1086/511159</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1058-4838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1058-4838'" tppabs="https://www.worldcat.org/issn/1058-4838" class="external text external">1058-4838</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17278083  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17278083'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17278083" class="external text external">17278083</a>.</cite></span></li><li id="cite_note-BTSCAPGuidelines-27"> <span id="mw-reference-text-cite_note-BTSCAPGuidelines-27" class="mw-reference-text"><cite id="CITEREFBTS_Pneumonia_Guidelines_Committee2004" class="citation web cs1">BTS Pneumonia Guidelines Committee (30 April 2004). <a href="javascript:if(confirm('https://web.archive.org/web/20090407092653/http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090407092653/http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf'" tppabs="https://web.archive.org/web/20090407092653/http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf" class="external text external">"BTS guidelines for the management of community acquired pneumonia in adults<span>&nbsp;</span>– 2004 update"</a> <span class="cs1-format">(PDF)</span>. British Thoracic Society. Archived from <a href="javascript:if(confirm('http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf'" tppabs="http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 7 April 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">30 June</span> 2009</span>.</cite></span></li><li id="cite_note-USHAPGuideline-28"> <span id="mw-reference-text-cite_note-USHAPGuideline-28" class="mw-reference-text"><cite id="CITEREFAmerican_Thoracic_SocietyInfectious_Diseases_Society2005" class="citation journal cs1">American Thoracic Society; Infectious Diseases Society (February 2005). <a href="javascript:if(confirm('https://semanticscholar.org/paper/c1e3c150b88a50d40302f15a5533bdd6b0da5885  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/c1e3c150b88a50d40302f15a5533bdd6b0da5885'" tppabs="https://semanticscholar.org/paper/c1e3c150b88a50d40302f15a5533bdd6b0da5885" class="external text external">"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia"</a>. <i>American Journal of Respiratory and Critical Care Medicine</i>. <b>171</b> (4): 388–416. doi:<a href="javascript:if(confirm('https://doi.org/10.1164%2Frccm.200405-644ST  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1164%2Frccm.200405-644ST'" tppabs="https://doi.org/10.1164%2Frccm.200405-644ST" class="external text external">10.1164/rccm.200405-644ST</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15699079  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15699079'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15699079" class="external text external">15699079</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFKoyaShibuyaKikkawaHaneda2004" class="citation journal cs1">Koya D, Shibuya K, Kikkawa R, Haneda M (December 2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544880  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544880'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544880" class="external text external">"Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report"</a>. <i>BMC Nephrology</i>. <b>5</b> (1): 18. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1471-2369-5-18  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1471-2369-5-18'" tppabs="https://doi.org/10.1186%2F1471-2369-5-18" class="external text external">10.1186/1471-2369-5-18</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544880  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544880'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544880" class="external text external">544880</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15610562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15610562'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15610562" class="external text external">15610562</a>.</cite></span></li><li id="cite_note-Barbachyn-30"> <span id="mw-reference-text-cite_note-Barbachyn-30" class="mw-reference-text"><cite id="CITEREFBarbachynFord2003" class="citation journal cs1">Barbachyn MR, Ford CW (May 2003). "Oxazolidinone structure-activity relationships leading to linezolid". <i>Angewandte Chemie International Edition in English</i>. <b>42</b> (18): 2010–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fanie.200200528  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fanie.200200528'" tppabs="https://doi.org/10.1002%2Fanie.200200528" class="external text external">10.1002/anie.200200528</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1433-7851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1433-7851'" tppabs="https://www.worldcat.org/issn/1433-7851" class="external text external">1433-7851</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12746812  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12746812'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12746812" class="external text external">12746812</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFPankeySabath2004" class="citation journal cs1">Pankey GA, Sabath LD (March 2004). <a href="javascript:if(confirm('https://doi.org/10.1086/381972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/381972'" tppabs="https://doi.org/10.1086/381972" class="external text external">"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections"</a>. <i>Clinical Infectious Diseases</i>. <b>38</b> (6): 864–70. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F381972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F381972'" tppabs="https://doi.org/10.1086%2F381972" class="external text external">10.1086/381972</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1058-4838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1058-4838'" tppabs="https://www.worldcat.org/issn/1058-4838" class="external text external">1058-4838</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14999632  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14999632'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14999632" class="external text external">14999632</a>.</cite></span></li><li id="cite_note-Falagas-32"> <span id="mw-reference-text-cite_note-Falagas-32" class="mw-reference-text"><cite id="CITEREFFalagasMantaNtzioraVardakas2006" class="citation journal cs1">Falagas ME, Manta KG, Ntziora F, Vardakas KZ (August 2006). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkl219  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkl219'" tppabs="https://doi.org/10.1093/jac/dkl219" class="external text external">"Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>58</b> (2): 273–80. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkl219  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkl219'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkl219" class="external text external">10.1093/jac/dkl219</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16735427  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16735427'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16735427" class="external text external">16735427</a>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFBabcockRitchieChristiansenStarlin2001" class="citation journal cs1">Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S (May 2001). <a href="javascript:if(confirm('https://doi.org/10.1086/319986  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/319986'" tppabs="https://doi.org/10.1086/319986" class="external text external">"Successful treatment of vancomycin-resistant <i>Enterococcus</i> endocarditis with oral linezolid"</a>. <i>Clinical Infectious Diseases</i>. <b>32</b> (9): 1373–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F319986  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F319986'" tppabs="https://doi.org/10.1086%2F319986" class="external text external">10.1086/319986</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1058-4838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1058-4838'" tppabs="https://www.worldcat.org/issn/1058-4838" class="external text external">1058-4838</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11303275  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11303275'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11303275" class="external text external">11303275</a>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite id="CITEREFAngLuaTurnerAsmar2003" class="citation journal cs1">Ang JY, Lua JL, Turner DR, Asmar BI (December 2003). "Vancomycin-resistant <i>Enterococcus faecium</i> endocarditis in a premature infant successfully treated with linezolid". <i>The Pediatric Infectious Disease Journal</i>. <b>22</b> (12): 1101–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F01.inf.0000101784.83146.0c  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F01.inf.0000101784.83146.0c'" tppabs="https://doi.org/10.1097%2F01.inf.0000101784.83146.0c" class="external text external">10.1097/01.inf.0000101784.83146.0c</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0891-3668  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0891-3668'" tppabs="https://www.worldcat.org/issn/0891-3668" class="external text external">0891-3668</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14688576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14688576'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14688576" class="external text external">14688576</a>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFArchuletaMurphyKeller2004" class="citation journal cs1">Archuleta S, Murphy B, Keller MJ (September 2004). "Successful treatment of vancomycin-resistant <i>Enterococcus faecium</i> endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection". <i>Transplant Infectious Disease</i>. <b>6</b> (3): 117–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1399-3062.2004.00059.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1399-3062.2004.00059.x'" tppabs="https://doi.org/10.1111%2Fj.1399-3062.2004.00059.x" class="external text external">10.1111/j.1399-3062.2004.00059.x</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1398-2273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1398-2273'" tppabs="https://www.worldcat.org/issn/1398-2273" class="external text external">1398-2273</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15569227  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15569227'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15569227" class="external text external">15569227</a>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFZimmerCaliendoThigpenSomani2003" class="citation journal cs1">Zimmer SM, Caliendo AM, Thigpen MC, Somani J (August 2003). "Failure of linezolid treatment for enterococcal endocarditis". <i>Clinical Infectious Diseases</i>. <b>37</b> (3): e29–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1086%2F375877  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F375877'" tppabs="https://doi.org/10.1086%2F375877" class="external text external">10.1086/375877</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1058-4838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1058-4838'" tppabs="https://www.worldcat.org/issn/1058-4838" class="external text external">1058-4838</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12884185  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12884185'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12884185" class="external text external">12884185</a>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite id="CITEREFTsigrelisSinghCoutinhoMurray2007" class="citation journal cs1">Tsigrelis C, Singh KV, Coutinho TD, Murray BE, Baddour LM (February 2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829077  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829077'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829077" class="external text external">"Vancomycin-Resistant Enterococcus faecalis Endocarditis: Linezolid Failure and Strain Characterization of Virulence Factors"</a>. <i>Journal of Clinical Microbiology</i>. <b>45</b> (2): 631–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FJCM.02188-06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FJCM.02188-06'" tppabs="https://doi.org/10.1128%2FJCM.02188-06" class="external text external">10.1128/JCM.02188-06</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829077  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829077'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1829077" class="external text external">1829077</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17182759  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17182759'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17182759" class="external text external">17182759</a>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFBerdalEskesen2008" class="citation journal cs1">Berdal JE, Eskesen A (2008). "Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis". <i>Scandinavian Journal of Infectious Diseases</i>. <b>40</b> (9): 765–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F00365540802087209  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F00365540802087209'" tppabs="https://doi.org/10.1080%2F00365540802087209" class="external text external">10.1080/00365540802087209</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0036-5548  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0036-5548'" tppabs="https://www.worldcat.org/issn/0036-5548" class="external text external">0036-5548</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18609208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18609208'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18609208" class="external text external">18609208</a>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFFalagasSiemposPapagelopoulosVardakas2007" class="citation journal cs1">Falagas ME, Siempos II, Papagelopoulos PJ, Vardakas KZ (March 2007). "Linezolid for the treatment of adults with bone and joint infections". <i>International Journal of Antimicrobial Agents</i>. <b>29</b> (3): 233–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijantimicag.2006.08.030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijantimicag.2006.08.030'" tppabs="https://doi.org/10.1016%2Fj.ijantimicag.2006.08.030" class="external text external">10.1016/j.ijantimicag.2006.08.030</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0924-8579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0924-8579'" tppabs="https://www.worldcat.org/issn/0924-8579" class="external text external">0924-8579</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17204407  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17204407'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17204407" class="external text external">17204407</a>.</cite> Review.</span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite id="CITEREFBassettiVitaleMelica2005" class="citation journal cs1">Bassetti M, Vitale F, Melica G,  et al. (March 2005). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dki016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dki016'" tppabs="https://doi.org/10.1093/jac/dki016" class="external text external">"Linezolid in the treatment of Gram-positive prosthetic joint infections"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>55</b> (3): 387–90. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdki016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdki016'" tppabs="https://doi.org/10.1093%2Fjac%2Fdki016" class="external text external">10.1093/jac/dki016</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15705640  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15705640'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15705640" class="external text external">15705640</a>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite id="CITEREFAneziokoroCannonPachuckiLentino2005" class="citation journal cs1">Aneziokoro CO, Cannon JP, Pachucki CT, Lentino JR (December 2005). "The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis". <i>Journal of Chemotherapy</i>. <b>17</b> (6): 643–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1179%2Fjoc.2005.17.6.643  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1179%2Fjoc.2005.17.6.643'" tppabs="https://doi.org/10.1179%2Fjoc.2005.17.6.643" class="external text external">10.1179/joc.2005.17.6.643</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1120-009X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1120-009X'" tppabs="https://www.worldcat.org/issn/1120-009X" class="external text external">1120-009X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16433195  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16433195'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16433195" class="external text external">16433195</a>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite id="CITEREFSennevilleLegoutValette2006" class="citation journal cs1">Senneville E, Legout L, Valette M,  et al. (August 2006). "Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study". <i>Clinical Therapeutics</i>. <b>28</b> (8): 1155–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.clinthera.2006.08.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.clinthera.2006.08.001'" tppabs="https://doi.org/10.1016%2Fj.clinthera.2006.08.001" class="external text external">10.1016/j.clinthera.2006.08.001</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0149-2918  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0149-2918'" tppabs="https://www.worldcat.org/issn/0149-2918" class="external text external">0149-2918</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16982292  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16982292'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16982292" class="external text external">16982292</a>.</cite></span></li><li id="cite_note-43"> <span id="mw-reference-text-cite_note-43" class="mw-reference-text"><cite id="CITEREFRaoHamilton2007" class="citation journal cs1">Rao N, Hamilton CW (October 2007). "Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series". <i>Diagnostic Microbiology and Infectious Disease</i>. <b>59</b> (2): 173–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.diagmicrobio.2007.04.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.diagmicrobio.2007.04.006'" tppabs="https://doi.org/10.1016%2Fj.diagmicrobio.2007.04.006" class="external text external">10.1016/j.diagmicrobio.2007.04.006</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0732-8893  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0732-8893'" tppabs="https://www.worldcat.org/issn/0732-8893" class="external text external">0732-8893</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17574788  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17574788'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17574788" class="external text external">17574788</a>.</cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite id="CITEREFPapadopoulosPlachourasGiannitsiotiPoulakou2009" class="citation journal cs1">Papadopoulos A, Plachouras D, Giannitsioti E, Poulakou G, Giamarellou H, Kanellakopoulou K (April 2009). "Efficacy and tolerability of linezolid in chronic osteomyelitis and prosthetic joint infections: a case-control study". <i>Journal of Chemotherapy</i>. <b>21</b> (2): 165–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1179%2Fjoc.2009.21.2.165  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1179%2Fjoc.2009.21.2.165'" tppabs="https://doi.org/10.1179%2Fjoc.2009.21.2.165" class="external text external">10.1179/joc.2009.21.2.165</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1120-009X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1120-009X'" tppabs="https://www.worldcat.org/issn/1120-009X" class="external text external">1120-009X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19423469  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19423469'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19423469" class="external text external">19423469</a>.</cite></span></li><li id="cite_note-Lippea2006-45"> <span id="mw-reference-text-cite_note-Lippea2006-45" class="mw-reference-text"><cite id="CITEREFvon_der_LippeSandvenBrubakk2006" class="citation journal cs1">von der Lippe B, Sandven P, Brubakk O (February 2006). "Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases". <i>The Journal of Infection</i>. <b>52</b> (2): 92–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jinf.2005.04.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jinf.2005.04.007'" tppabs="https://doi.org/10.1016%2Fj.jinf.2005.04.007" class="external text external">10.1016/j.jinf.2005.04.007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15907341  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15907341'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15907341" class="external text external">15907341</a>.</cite></span></li><li id="cite_note-Park2006-46"> <span id="mw-reference-text-cite_note-Park2006-46" class="mw-reference-text"><cite id="CITEREFParkHongOhKim2006" class="citation journal cs1">Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS (September 2006). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkl298  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkl298'" tppabs="https://doi.org/10.1093/jac/dkl298" class="external text external">"Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis"</a>. <i>The Journal of Antimicrobial Chemotherapy</i>. <b>58</b> (3): 701–4. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkl298  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkl298'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkl298" class="external text external">10.1093/jac/dkl298</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16857689  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16857689'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16857689" class="external text external">16857689</a>.</cite></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite id="CITEREFFortúnMartín-DávilaNavasPérez-Elías2005" class="citation journal cs1">Fortún J, Martín-Dávila P, Navas E, Pérez-Elías MJ, Cobo J, Tato M,  et al. (July 2005). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dki148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dki148'" tppabs="https://doi.org/10.1093/jac/dki148" class="external text external">"Linezolid for the treatment of multidrug-resistant tuberculosis"</a>. <i>The Journal of Antimicrobial Chemotherapy</i>. <b>56</b> (1): 180–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdki148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdki148'" tppabs="https://doi.org/10.1093%2Fjac%2Fdki148" class="external text external">10.1093/jac/dki148</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15911549  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15911549'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15911549" class="external text external">15911549</a>.</cite></span></li><li id="cite_note-48"> <span id="mw-reference-text-cite_note-48" class="mw-reference-text"><cite id="CITEREFJaksicMartinelliPerez-OteyzaHartman2006" class="citation journal cs1">Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ (March 2006). <a href="javascript:if(confirm('https://doi.org/10.1086/500139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/500139'" tppabs="https://doi.org/10.1086/500139" class="external text external">"Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer"</a>. <i>Clinical Infectious Diseases</i>. <b>42</b> (5): 597–607. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F500139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F500139'" tppabs="https://doi.org/10.1086%2F500139" class="external text external">10.1086/500139</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1058-4838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1058-4838'" tppabs="https://www.worldcat.org/issn/1058-4838" class="external text external">1058-4838</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16447103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16447103'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16447103" class="external text external">16447103</a>.</cite> Criticism in doi<span>:</span><a href="javascript:if(confirm('https://doi.org/10.1086%2F504431  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F504431'" tppabs="https://doi.org/10.1086%2F504431" class="external text external">10.1086/504431</a>; author reply in doi<span>:</span><a href="javascript:if(confirm('https://doi.org/10.1086%2F504437  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F504437'" tppabs="https://doi.org/10.1086%2F504437" class="external text external">10.1086/504437</a>.</span></li><li id="cite_note-Moellering-49"> <span id="mw-reference-text-cite_note-Moellering-49" class="mw-reference-text"><cite id="CITEREFMoellering_RC2003" class="citation journal cs1">Moellering RC (January 2003). <a href="javascript:if(confirm('http://memberfiles.freewebs.com/53/35/75763553/documents/Linezolid%20The%20First%20Oxazolidinone%20Antimicrobial.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://memberfiles.freewebs.com/53/35/75763553/documents/Linezolid%20The%20First%20Oxazolidinone%20Antimicrobial.pdf'" tppabs="http://memberfiles.freewebs.com/53/35/75763553/documents/Linezolid%20The%20First%20Oxazolidinone%20Antimicrobial.pdf" class="external text external">"Linezolid: the first oxazolidinone antimicrobial"</a> <span class="cs1-format">(PDF)</span>. <i>Annals of Internal Medicine</i>. <b>138</b> (2): 135–42. doi:<a href="javascript:if(confirm('https://doi.org/10.7326%2F0003-4819-138-2-200301210-00015  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7326%2F0003-4819-138-2-200301210-00015'" tppabs="https://doi.org/10.7326%2F0003-4819-138-2-200301210-00015" class="external text external">10.7326/0003-4819-138-2-200301210-00015</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0003-4819  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0003-4819'" tppabs="https://www.worldcat.org/issn/0003-4819" class="external text external">0003-4819</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12529096  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12529096'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12529096" class="external text external">12529096</a>.</cite></span></li><li id="cite_note-50"> <span id="mw-reference-text-cite_note-50" class="mw-reference-text"><cite id="CITEREFCottagnoudGerberAcostaCottagnoud2000" class="citation journal cs1">Cottagnoud P, Gerber CM, Acosta F, Cottagnoud M, Neftel K, Täuber MG (December 2000). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/46.6.981  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/46.6.981'" tppabs="https://doi.org/10.1093/jac/46.6.981" class="external text external">"Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>46</b> (6): 981–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2F46.6.981  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2F46.6.981'" tppabs="https://doi.org/10.1093%2Fjac%2F46.6.981" class="external text external">10.1093/jac/46.6.981</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11102418  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11102418'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11102418" class="external text external">11102418</a>.</cite></span></li><li id="cite_note-Sabbatani-51"> <span id="mw-reference-text-cite_note-Sabbatani-51" class="mw-reference-text"><cite id="CITEREFSabbataniManfrediFrankChiodo2005" class="citation journal cs1">Sabbatani S, Manfredi R, Frank G, Chiodo F (June 2005). <a href="javascript:if(confirm('https://web.archive.org/web/20110722035501/http://www.infezmed.it/VisualizzaUnArticolo.aspx?Anno=2005&numero=2&ArticoloDaVisualizzare=Vol_13_2_2005_8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110722035501/http://www.infezmed.it/VisualizzaUnArticolo.aspx?Anno=2005&numero=2&ArticoloDaVisualizzare=Vol_13_2_2005_8'" tppabs="https://web.archive.org/web/20110722035501/http://www.infezmed.it/VisualizzaUnArticolo.aspx?Anno=2005&numero=2&ArticoloDaVisualizzare=Vol_13_2_2005_8" class="external text external">"Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds"</a>. <i>Le Infezioni in Medicina</i>. <b>13</b> (2): 112–9. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1124-9390  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1124-9390'" tppabs="https://www.worldcat.org/issn/1124-9390" class="external text external">1124-9390</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16220032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16220032'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16220032" class="external text external">16220032</a>. Archived from <a href="javascript:if(confirm('http://www.infezmed.it/VisualizzaUnArticolo.aspx?Anno=2005&numero=2&ArticoloDaVisualizzare=Vol_13_2_2005_8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.infezmed.it/VisualizzaUnArticolo.aspx?Anno=2005&numero=2&ArticoloDaVisualizzare=Vol_13_2_2005_8'" tppabs="http://www.infezmed.it/VisualizzaUnArticolo.aspx?Anno=2005&numero=2&ArticoloDaVisualizzare=Vol_13_2_2005_8" class="external text external">the original</a> on 22 July 2011.</cite></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite id="CITEREFNtzioraFalagas2007" class="citation journal cs1">Ntziora F, Falagas ME (February 2007). "Linezolid for the treatment of patients with central nervous system infection". <i>Annals of Pharmacotherapy</i>. <b>41</b> (2): 296–308. doi:<a href="javascript:if(confirm('https://doi.org/10.1345%2Faph.1H307  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1345%2Faph.1H307'" tppabs="https://doi.org/10.1345%2Faph.1H307" class="external text external">10.1345/aph.1H307</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1060-0280  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1060-0280'" tppabs="https://www.worldcat.org/issn/1060-0280" class="external text external">1060-0280</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17284501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17284501'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17284501" class="external text external">17284501</a>.</cite> Structured abstract with quality assessment available at <a href="javascript:if(confirm('http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12007005296  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12007005296'" tppabs="http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12007005296" class="external text external">DARE</a> <a href="javascript:if(confirm('https://web.archive.org/web/20110902114025/http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12007005296  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110902114025/http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12007005296'" tppabs="https://web.archive.org/web/20110902114025/http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12007005296" class="external text external">Archived</a><span> 2 September 2011 at the </span>Wayback Machine.</span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><cite id="CITEREFTunkelHartmanKaplan2004" class="citation journal cs1">Tunkel AR, Hartman BJ, Kaplan SL,  et al. (November 2004). <a href="javascript:if(confirm('https://doi.org/10.1086/425368  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/425368'" tppabs="https://doi.org/10.1086/425368" class="external text external">"Practice guidelines for the management of bacterial meningitis"</a>. <i>Clinical Infectious Diseases</i>. <b>39</b> (9): 1267–84. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F425368  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F425368'" tppabs="https://doi.org/10.1086%2F425368" class="external text external">10.1086/425368</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1058-4838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1058-4838'" tppabs="https://www.worldcat.org/issn/1058-4838" class="external text external">1058-4838</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15494903  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15494903'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15494903" class="external text external">15494903</a>.</cite></span></li><li id="cite_note-Naesens-54"> <span id="mw-reference-text-cite_note-Naesens-54" class="mw-reference-text"><cite id="CITEREFNaesensRonsynDruwéDenis2009" class="citation journal cs1">Naesens R, Ronsyn M, Druwé P, Denis O, Ieven M, Jeurissen A (June 2009). "Central nervous system invasion by community-acquired methicillin-resistant <i>Staphylococcus aureus</i>: case report and review of the literature". <i>Journal of Medical Microbiology</i>. <b>58</b> (Pt 9): 1247–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1099%2Fjmm.0.011130-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1099%2Fjmm.0.011130-0'" tppabs="https://doi.org/10.1099%2Fjmm.0.011130-0" class="external text external">10.1099/jmm.0.011130-0</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0022-2615  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0022-2615'" tppabs="https://www.worldcat.org/issn/0022-2615" class="external text external">0022-2615</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19528145  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19528145'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19528145" class="external text external">19528145</a>.</cite></span></li><li id="cite_note-CRBSI-55"> <span id="mw-reference-text-cite_note-CRBSI-55" class="mw-reference-text"><cite id="CITEREF[No_authors_listed]2007" class="citation web cs1">[No authors listed] (16 March 2007). <a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085249.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085249.htm'" tppabs="https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085249.htm" class="external text external">"Information for Healthcare Professionals: Linezolid (marketed as Zyvox)"</a>. U.S. Food and Drug Administration (FDA). <a href="javascript:if(confirm('https://web.archive.org/web/20101019044734/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085249.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20101019044734/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085249.htm'" tppabs="https://web.archive.org/web/20101019044734/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085249.htm" class="external text external">Archived</a> from the original on 19 October 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">15 September</span> 2010</span>.</cite></span></li><li id="cite_note-Wilcox-56"> <span id="mw-reference-text-cite_note-Wilcox-56" class="mw-reference-text"><cite id="CITEREFWilcoxTackBouza2009" class="citation journal cs1">Wilcox MH, Tack KJ, Bouza E,  et al. (January 2009). <a href="javascript:if(confirm('https://doi.org/10.1086/595686  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/595686'" tppabs="https://doi.org/10.1086/595686" class="external text external">"Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study"</a>. <i>Clinical Infectious Diseases</i>. <b>48</b> (2): 203–12. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F595686  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F595686'" tppabs="https://doi.org/10.1086%2F595686" class="external text external">10.1086/595686</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1058-4838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1058-4838'" tppabs="https://www.worldcat.org/issn/1058-4838" class="external text external">1058-4838</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19072714  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19072714'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19072714" class="external text external">19072714</a>.</cite></span></li><li id="cite_note-American_Family_Physician-57"> <span id="mw-reference-text-cite_note-American_Family_Physician-57" class="mw-reference-text"><cite id="CITEREFAmentJamshedHorne2002" class="citation journal cs1">Ament PW, Jamshed N, Horne JP (February 2002). <a href="javascript:if(confirm('http://www.aafp.org/afp/20020215/663.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.aafp.org/afp/20020215/663.html'" tppabs="http://www.aafp.org/afp/20020215/663.html" class="external text external">"Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections"</a>. <i>American Family Physician</i>. <b>65</b> (4): 663–70. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0002-838X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0002-838X'" tppabs="https://www.worldcat.org/issn/0002-838X" class="external text external">0002-838X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11871684  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11871684'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11871684" class="external text external">11871684</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20080724045942/http://www.aafp.org/afp/20020215/663.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080724045942/http://www.aafp.org/afp/20020215/663.html'" tppabs="https://web.archive.org/web/20080724045942/http://www.aafp.org/afp/20020215/663.html" class="external text external">Archived</a> from the original on 24 July 2008.</cite></span></li><li id="cite_note-Buck-58"> <span id="mw-reference-text-cite_note-Buck-58" class="mw-reference-text"><cite id="CITEREFBuck_ML2003" class="citation journal cs1">Buck ML (June 2003). <a href="javascript:if(confirm('https://web.archive.org/web/20110605115607/http://www.healthsystem.virginia.edu/alive/pediatrics/PharmNews/200306.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110605115607/http://www.healthsystem.virginia.edu/alive/pediatrics/PharmNews/200306.pdf'" tppabs="https://web.archive.org/web/20110605115607/http://www.healthsystem.virginia.edu/alive/pediatrics/PharmNews/200306.pdf" class="external text external">"Linezolid use for resistant Gram-positive infections in children"</a> <span class="cs1-format">(PDF)</span>. <i>Pediatric Pharmacotherapy</i>. <b>9</b> (6). Archived from <a href="javascript:if(confirm('http://www.healthsystem.virginia.edu/alive/pediatrics/PharmNews/200306.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.healthsystem.virginia.edu/alive/pediatrics/PharmNews/200306.pdf'" tppabs="http://www.healthsystem.virginia.edu/alive/pediatrics/PharmNews/200306.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 5 June 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2009</span>.</cite></span></li><li id="cite_note-Lexi-Comp-59"> <span id="mw-reference-text-cite_note-Lexi-Comp-59" class="mw-reference-text"><cite id="CITEREFLexi-Comp2008" class="citation web cs1">Lexi-Comp (August 2008). <a href="javascript:if(confirm('http://www.merck.com/mmpe/lexicomp/linezolid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.merck.com/mmpe/lexicomp/linezolid.html'" tppabs="http://www.merck.com/mmpe/lexicomp/linezolid.html" class="external text external">"Linezolid"</a>. <i>The Merck Manual Professional</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20090426220140/http://www.merck.com/mmpe/lexicomp/linezolid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090426220140/http://www.merck.com/mmpe/lexicomp/linezolid.html'" tppabs="https://web.archive.org/web/20090426220140/http://www.merck.com/mmpe/lexicomp/linezolid.html" class="external text external">Archived</a> from the original on 26 April 2009.</cite> Retrieved on 14 May 2009.</span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite id="CITEREFLoveringLe_FlochHovsepian2009" class="citation journal cs1">Lovering AM, Le Floch R, Hovsepian L,  et al. (March 2009). "Pharmacokinetic evaluation of linezolid in patients with major thermal injuries". <i>Journal of Antimicrobial Chemotherapy</i>. <b>63</b> (3): 553–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkn541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkn541'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkn541" class="external text external">10.1093/jac/dkn541</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0305-7453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0305-7453'" tppabs="https://www.worldcat.org/issn/0305-7453" class="external text external">0305-7453</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19153078  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19153078'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19153078" class="external text external">19153078</a>.</cite></span></li><li id="cite_note-InfectiousDiseases-61"> <span id="mw-reference-text-cite_note-InfectiousDiseases-61" class="mw-reference-text"><cite id="CITEREFDavaroGlewDaly2004" class="citation book cs1">Davaro RE, Glew RH, Daly JS (2004). <a href="javascript:if(confirm('https://books.google.com/books?id=91altE1evAsC&pg=PP241  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=91altE1evAsC&pg=PP241'" tppabs="https://books.google.com/books?id=91altE1evAsC&pg=PP241" class="external text external">"Oxazolidinones, quinupristin-dalfopristin, and daptomycin"</a>.  In Gorbach SL, Bartlett JG, Blacklow NR (eds.). <i>Infectious diseases</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>241–3. ISBN<span>&nbsp;</span><bdi>978-0-7817-3371-7</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">20 June</span> 2009</span>.</cite></span></li><li id="cite_note-Jones-62"> <span id="mw-reference-text-cite_note-Jones-62" class="mw-reference-text"><cite id="CITEREFJonesStilwellHoganSheehan2007" class="citation journal cs1">Jones RN, Stilwell MG, Hogan PA, Sheehan DJ (April 2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855453'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855453" class="external text external">"Activity of Linezolid against 3,251 Strains of Uncommonly Isolated Gram-Positive Organisms: Report from the SENTRY Antimicrobial Surveillance Program"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>51</b> (4): 1491–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.01496-06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.01496-06'" tppabs="https://doi.org/10.1128%2FAAC.01496-06" class="external text external">10.1128/AAC.01496-06</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855453'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855453" class="external text external">1855453</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17210770  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17210770'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17210770" class="external text external">17210770</a>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite id="CITEREFJodlowskiMelnychukConry2007" class="citation journal cs1">Jodlowski TZ, Melnychuk I, Conry J (October 2007). "Linezolid for the treatment of <i>Nocardia</i> spp. infections". <i>Annals of Pharmacotherapy</i>. <b>41</b> (10): 1694–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1345%2Faph.1K196  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1345%2Faph.1K196'" tppabs="https://doi.org/10.1345%2Faph.1K196" class="external text external">10.1345/aph.1K196</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1060-0280  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1060-0280'" tppabs="https://www.worldcat.org/issn/1060-0280" class="external text external">1060-0280</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17785610  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17785610'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17785610" class="external text external">17785610</a>.</cite></span></li><li id="cite_note-DrugTherPerspect-64"> <span id="mw-reference-text-cite_note-DrugTherPerspect-64" class="mw-reference-text"><cite id="CITEREF[No_authors_listed]2001" class="citation journal cs1">[No authors listed] (2001). <a href="javascript:if(confirm('http://www.medscape.com/viewarticle/406493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/406493'" tppabs="http://www.medscape.com/viewarticle/406493" class="external text external">"Linezolid: First of a New Drug Class for Gram-Positive Infections"</a>. <i>Drugs &amp; Therapy Perspectives</i>. <b>17</b> (9): 1–6. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00042310-200117090-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00042310-200117090-00001'" tppabs="https://doi.org/10.2165%2F00042310-200117090-00001" class="external text external">10.2165/00042310-200117090-00001</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20130521043752/http://www.medscape.com/viewarticle/406493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130521043752/http://www.medscape.com/viewarticle/406493'" tppabs="https://web.archive.org/web/20130521043752/http://www.medscape.com/viewarticle/406493" class="external text external">Archived</a> from the original on 21 May 2013.</cite> Free full text with registration at Medscape.</span></li><li id="cite_note-65"> <span id="mw-reference-text-cite_note-65" class="mw-reference-text"><cite id="CITEREF[No_authors_listed]2008" class="citation web cs1">[No authors listed] (5 August 2008). <a href="javascript:if(confirm('https://web.archive.org/web/20100126195237/http://www.hpa.org.uk/webw/HPAweb%26HPAwebStandard/HPAweb_C/1195733833519?p=1203409654995  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100126195237/http://www.hpa.org.uk/webw/HPAweb%26HPAwebStandard/HPAweb_C/1195733833519?p=1203409654995'" tppabs="https://web.archive.org/web/20100126195237/http://www.hpa.org.uk/webw/HPAweb%26HPAwebStandard/HPAweb_C/1195733833519?p=1203409654995" class="external text external">"Animal Bites and <i>Pasteurella multocida</i>: Information for Healthcare Staff"</a>. Health Protection Agency. Archived from <a href="javascript:if(confirm('http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1195733833519?p=1203409654995  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1195733833519?p=1203409654995'" tppabs="http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1195733833519?p=1203409654995" class="external text external">the original</a> on 26 January 2010.</cite> Retrieved on 15 May 2009.</span></li><li id="cite_note-66"> <span id="mw-reference-text-cite_note-66" class="mw-reference-text"><cite id="CITEREFGeislerMalhotraStamm2001" class="citation journal cs1">Geisler WM, Malhotra U, Stamm WE (December 2001). <a href="javascript:if(confirm('https://doi.org/10.1038/sj.bmt.1703288  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038/sj.bmt.1703288'" tppabs="https://doi.org/10.1038/sj.bmt.1703288" class="external text external">"Pneumonia and sepsis due to fluoroquinolone-resistant <i>Capnocytophaga gingivalis</i> after autologous stem cell transplantation"</a>. <i>Bone Marrow Transplantation</i>. <b>28</b> (12): 1171–3. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.bmt.1703288  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.bmt.1703288'" tppabs="https://doi.org/10.1038%2Fsj.bmt.1703288" class="external text external">10.1038/sj.bmt.1703288</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0268-3369  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0268-3369'" tppabs="https://www.worldcat.org/issn/0268-3369" class="external text external">0268-3369</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11803363  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11803363'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11803363" class="external text external">11803363</a>.</cite></span></li><li id="cite_note-Livermore-67"> <span id="mw-reference-text-cite_note-Livermore-67" class="mw-reference-text"><cite id="CITEREFLivermore_DM2000" class="citation journal cs1">Livermore DM (September 2000). <a href="javascript:if(confirm('http://jac.oxfordjournals.org/content/46/3/347.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jac.oxfordjournals.org/content/46/3/347.full.pdf'" tppabs="http://jac.oxfordjournals.org/content/46/3/347.full.pdf" class="external text external">"Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?"</a> <span class="cs1-format">(PDF)</span>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>46</b> (3): 347–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2F46.3.347  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2F46.3.347'" tppabs="https://doi.org/10.1093%2Fjac%2F46.3.347" class="external text external">10.1093/jac/46.3.347</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0305-7453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0305-7453'" tppabs="https://www.worldcat.org/issn/0305-7453" class="external text external">0305-7453</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10980159  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10980159'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10980159" class="external text external">10980159</a>.</cite></span></li><li id="cite_note-French-68"> <span id="mw-reference-text-cite_note-French-68" class="mw-reference-text"><cite id="CITEREFFrench2003" class="citation journal cs1">French G (May 2003). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkg253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkg253'" tppabs="https://doi.org/10.1093/jac/dkg253" class="external text external">"Safety and tolerability of linezolid"</a>. <i>The Journal of Antimicrobial Chemotherapy</i>. 51 Suppl 2 (Suppl 2): ii45–53. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkg253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkg253'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkg253" class="external text external">10.1093/jac/dkg253</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12730142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12730142'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12730142" class="external text external">12730142</a>.</cite> Review. Includes extensive discussion of the hematological adverse effects of linezolid.</span></li><li id="cite_note-Metaxas-69"> <span id="mw-reference-text-cite_note-Metaxas-69" class="mw-reference-text"><cite id="CITEREFMetaxasFalagas2009" class="citation journal cs1">Metaxas EI, Falagas ME (July 2009). "Update on the safety of linezolid". <i>Expert Opinion on Drug Safety</i>. <b>8</b> (4): 485–91. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740330903049706  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740330903049706'" tppabs="https://doi.org/10.1517%2F14740330903049706" class="external text external">10.1517/14740330903049706</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19538105  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19538105'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19538105" class="external text external">19538105</a>.</cite></span></li><li id="cite_note-70"> <span id="mw-reference-text-cite_note-70" class="mw-reference-text"><cite id="CITEREFZabelWorm2005" class="citation journal cs1">Zabel LT, Worm S (June 2005). "Linezolid contributed to Clostridium difficile colitis with fatal outcome". <i>Infection</i>. <b>33</b> (3): 155–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs15010-005-4112-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs15010-005-4112-6'" tppabs="https://doi.org/10.1007%2Fs15010-005-4112-6" class="external text external">10.1007/s15010-005-4112-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15940418  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15940418'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15940418" class="external text external">15940418</a>.</cite></span></li><li id="cite_note-71"> <span id="mw-reference-text-cite_note-71" class="mw-reference-text"><cite id="CITEREFPeláezAlonsoPérezAlcalá2002" class="citation journal cs1">Peláez T, Alonso R, Pérez C, Alcalá L, Cuevas O, Bouza E (May 2002). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127182  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127182'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127182" class="external text external">"In vitro activity of linezolid against Clostridium difficile"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>46</b> (5): 1617–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.46.5.1617-1618.2002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.46.5.1617-1618.2002'" tppabs="https://doi.org/10.1128%2FAAC.46.5.1617-1618.2002" class="external text external">10.1128/AAC.46.5.1617-1618.2002</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127182  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127182'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127182" class="external text external">127182</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11959617  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11959617'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11959617" class="external text external">11959617</a>.</cite></span></li><li id="cite_note-72"> <span id="mw-reference-text-cite_note-72" class="mw-reference-text"><cite id="CITEREFLinWuTsai2006" class="citation journal cs1">Lin YH, Wu VC, Tsai IJ,  et al. (October 2006). "High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency". <i>International Journal of Antimicrobial Agents</i>. <b>28</b> (4): 345–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijantimicag.2006.04.017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijantimicag.2006.04.017'" tppabs="https://doi.org/10.1016%2Fj.ijantimicag.2006.04.017" class="external text external">10.1016/j.ijantimicag.2006.04.017</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0924-8579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0924-8579'" tppabs="https://www.worldcat.org/issn/0924-8579" class="external text external">0924-8579</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16935472  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16935472'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16935472" class="external text external">16935472</a>.</cite></span></li><li id="cite_note-73"> <span id="mw-reference-text-cite_note-73" class="mw-reference-text"><cite id="CITEREFSpellbergYooBayer2004" class="citation journal cs1">Spellberg B, Yoo T, Bayer AS (October 2004). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkh405  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkh405'" tppabs="https://doi.org/10.1093/jac/dkh405" class="external text external">"Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>54</b> (4): 832–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkh405  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkh405'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkh405" class="external text external">10.1093/jac/dkh405</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15317746  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15317746'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15317746" class="external text external">15317746</a>.</cite></span></li><li id="cite_note-74"> <span id="mw-reference-text-cite_note-74" class="mw-reference-text"><cite id="CITEREFPlachourasGiannitsiotiAthanassia2006" class="citation journal cs1">Plachouras D, Giannitsioti E, Athanassia S,  et al. (November 2006). <a href="javascript:if(confirm('https://doi.org/10.1086/508280  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/508280'" tppabs="https://doi.org/10.1086/508280" class="external text external">"No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment"</a>. <i>Clinical Infectious Diseases</i>. <b>43</b> (9): e89–91. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F508280  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F508280'" tppabs="https://doi.org/10.1086%2F508280" class="external text external">10.1086/508280</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1058-4838  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1058-4838'" tppabs="https://www.worldcat.org/issn/1058-4838" class="external text external">1058-4838</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17029128  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17029128'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17029128" class="external text external">17029128</a>.</cite></span></li><li id="cite_note-NCI-75"> <span id="mw-reference-text-cite_note-NCI-75" class="mw-reference-text"><span class="citation">del Pino BM.<span> </span><span> </span><a href="javascript:if(confirm('http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/022310/page6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/022310/page6'" tppabs="http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/022310/page6" class="external text external">Chemotherapy-induced Peripheral Neuropathy</a>.<span> </span><i>NCI Cancer Bulletin</i>.<span> </span>23 February 2010<span> </span><span>[</span><a href="javascript:if(confirm('https://web.archive.org/web/20111211105234/http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/022310/page6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20111211105234/http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/022310/page6'" tppabs="https://web.archive.org/web/20111211105234/http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/022310/page6" class="external text external">archived</a> 11 December 2011<span>]</span>;7(4):6.</span></span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text"><cite id="CITEREFCooperDeakin2016" class="citation book cs1">Cooper R, Deakin JJ (2016). <a href="javascript:if(confirm('https://books.google.com/books?id=aXGmCwAAQBAJ&pg=PA46  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=aXGmCwAAQBAJ&pg=PA46'" tppabs="https://books.google.com/books?id=aXGmCwAAQBAJ&pg=PA46" class="external text external">"Africa's gift to the world"</a>. <i>Botanical Miracles: Chemistry of Plants That Changed the World</i>. CRC Press. pp.<span>&nbsp;</span>46–51. ISBN<span>&nbsp;</span><bdi>9781498704304</bdi>.</cite></span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text"><cite id="CITEREFKeglevichHazaiKalausSzántay2012" class="citation journal cs1">Keglevich P, Hazai L, Kalaus G, Szántay C (May 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268133  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268133'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268133" class="external text external">"Modifications on the basic skeletons of vinblastine and vincristine"</a>. <i>Molecules</i>. <b>17</b> (5): 5893–914. doi:<a href="javascript:if(confirm('https://doi.org/10.3390%2Fmolecules17055893  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3390%2Fmolecules17055893'" tppabs="https://doi.org/10.3390%2Fmolecules17055893" class="external text external">10.3390/molecules17055893</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268133  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268133'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268133" class="external text external">6268133</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22609781  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22609781'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22609781" class="external text external">22609781</a>.</cite></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text"><cite id="CITEREFRaviña2011" class="citation book cs1">Raviña E (2011). <a href="javascript:if(confirm('https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA157  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA157'" tppabs="https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA157" class="external text external">"Vinca alkaloids"</a>. <i>The evolution of drug discovery: From traditional medicines to modern drugs</i>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>157–159. ISBN<span>&nbsp;</span><bdi>9783527326693</bdi>.</cite></span></li><li id="cite_note-79"> <span id="mw-reference-text-cite_note-79" class="mw-reference-text"><span class="citation"><span> </span><a href="javascript:if(confirm('http://www.kup.at/kup/pdf/10376.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.kup.at/kup/pdf/10376.pdf'" tppabs="http://www.kup.at/kup/pdf/10376.pdf" class="external text external">Chemotherapy and polyneuropathies</a>.<span> </span><i>European Association of Neurooncology Magazine</i>.<span> </span>2012<span> </span><span>[</span><a href="javascript:if(confirm('https://web.archive.org/web/20141006125234/http://www.kup.at/kup/pdf/10376.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141006125234/http://www.kup.at/kup/pdf/10376.pdf'" tppabs="https://web.archive.org/web/20141006125234/http://www.kup.at/kup/pdf/10376.pdf" class="external text external">archived</a> 6 October 2014<span>]</span>;12(1).</span></span></li><li id="cite_note-80"> <span id="mw-reference-text-cite_note-80" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ehealthme.com/ds/herceptin/peripheral%20sensory%20neuropathy  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ehealthme.com/ds/herceptin/peripheral%20sensory%20neuropathy'" tppabs="http://www.ehealthme.com/ds/herceptin/peripheral%20sensory%20neuropathy" class="external text external">"Review: could Herceptin cause Peripheral sensory neuropathy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20160317105901/http://www.ehealthme.com/ds/herceptin/peripheral%20sensory%20neuropathy  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160317105901/http://www.ehealthme.com/ds/herceptin/peripheral%20sensory%20neuropathy'" tppabs="https://web.archive.org/web/20160317105901/http://www.ehealthme.com/ds/herceptin/peripheral%20sensory%20neuropathy" class="external text external">Archived</a> from the original on 17 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">4 May</span> 2016</span>.</cite></span></li><li id="cite_note-Narita-81"> <span id="mw-reference-text-cite_note-Narita-81" class="mw-reference-text"><cite id="CITEREFNaritaTsujiYu2007" class="citation journal cs1">Narita M, Tsuji BT, Yu VL (August 2007). "Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome". <i>Pharmacotherapy</i>. <b>27</b> (8): 1189–97. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.27.8.1189  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.27.8.1189'" tppabs="https://doi.org/10.1592%2Fphco.27.8.1189" class="external text external">10.1592/phco.27.8.1189</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17655517  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17655517'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17655517" class="external text external">17655517</a>.</cite></span></li><li id="cite_note-Bressler-82"> <span id="mw-reference-text-cite_note-Bressler-82" class="mw-reference-text"><cite id="CITEREFBresslerZimmerGilmoreSomani2004" class="citation journal cs1">Bressler AM, Zimmer SM, Gilmore JL, Somani J (August 2004). "Peripheral neuropathy associated with prolonged use of linezolid". <i>The Lancet. Infectious Diseases</i>. <b>4</b> (8): 528–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1473-3099%2804%2901109-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1473-3099%2804%2901109-0'" tppabs="https://doi.org/10.1016%2FS1473-3099%2804%2901109-0" class="external text external">10.1016/S1473-3099(04)01109-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15288827  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15288827'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15288827" class="external text external">15288827</a>.</cite></span></li><li id="cite_note-Brown-83"> <span id="mw-reference-text-cite_note-Brown-83" class="mw-reference-text"><cite id="CITEREFBrownAitkenvan_Manen2011" class="citation journal cs1">Brown J, Aitken SL, van Manen RP (June 2011). "Potential for linezolid-related blindness: a review of spontaneous adverse event reports". <i>Pharmacotherapy</i>. <b>31</b> (6): 585–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.31.6.585  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.31.6.585'" tppabs="https://doi.org/10.1592%2Fphco.31.6.585" class="external text external">10.1592/phco.31.6.585</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21923442  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21923442'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21923442" class="external text external">21923442</a>.</cite></span></li><li id="cite_note-pmid17766431-84"> <span id="mw-reference-text-cite_note-pmid17766431-84" class="mw-reference-text"><cite id="CITEREFChaoSunChangHsieh2008" class="citation journal cs1">Chao CC, Sun HY, Chang YC, Hsieh ST (January 2008). <a href="javascript:if(confirm('https://semanticscholar.org/paper/a5e4890032989e00df84ced66389009cab801612  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/a5e4890032989e00df84ced66389009cab801612'" tppabs="https://semanticscholar.org/paper/a5e4890032989e00df84ced66389009cab801612" class="external text external">"Painful neuropathy with skin denervation after prolonged use of linezolid"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>79</b> (1): 97–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fjnnp.2007.127910  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fjnnp.2007.127910'" tppabs="https://doi.org/10.1136%2Fjnnp.2007.127910" class="external text external">10.1136/jnnp.2007.127910</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17766431  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17766431'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17766431" class="external text external">17766431</a>.</cite></span></li><li id="cite_note-85"> <span id="mw-reference-text-cite_note-85" class="mw-reference-text"><cite id="CITEREFSaijoHayashiYamadaWakakura2005" class="citation journal cs1">Saijo T, Hayashi K, Yamada H, Wakakura M (June 2005). "Linezolid-induced optic neuropathy". <i>American Journal of Ophthalmology</i>. <b>139</b> (6): 1114–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ajo.2004.11.047  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ajo.2004.11.047'" tppabs="https://doi.org/10.1016%2Fj.ajo.2004.11.047" class="external text external">10.1016/j.ajo.2004.11.047</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15953450  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15953450'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15953450" class="external text external">15953450</a>.</cite></span></li><li id="cite_note-Barnhill-86"> <span id="mw-reference-text-cite_note-Barnhill-86" class="mw-reference-text"><cite id="CITEREFBarnhillBrewerCarlson2012" class="citation journal cs1">Barnhill AE, Brewer MT, Carlson SA (August 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421593'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421593" class="external text external">"Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>56</b> (8): 4046–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.00678-12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.00678-12'" tppabs="https://doi.org/10.1128%2FAAC.00678-12" class="external text external">10.1128/AAC.00678-12</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421593'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421593" class="external text external">3421593</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22615289  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22615289'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22615289" class="external text external">22615289</a>.</cite> Review. For the original case series, see <cite id="CITEREFSorianoMiróMensa2005" class="citation journal cs1">Soriano A, Miró O, Mensa J (November 2005). "Mitochondrial toxicity associated with linezolid". <i>The New England Journal of Medicine</i>. <b>353</b> (21): 2305–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM200511243532123  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM200511243532123'" tppabs="https://doi.org/10.1056%2FNEJM200511243532123" class="external text external">10.1056/NEJM200511243532123</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16306535  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16306535'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16306535" class="external text external">16306535</a>.</cite></span></li><li id="cite_note-Javaheri-87"> <span id="mw-reference-text-cite_note-Javaheri-87" class="mw-reference-text"><cite id="CITEREFJavaheriKhuranaO'hearnLai2007" class="citation journal cs1">Javaheri M, Khurana RN, O'hearn TM, Lai MM, Sadun AA (January 2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857552  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857552'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857552" class="external text external">"Linezolid-induced optic neuropathy: a mitochondrial disorder?"</a>. <i>The British Journal of Ophthalmology</i>. <b>91</b> (1): 111–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbjo.2006.102541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbjo.2006.102541'" tppabs="https://doi.org/10.1136%2Fbjo.2006.102541" class="external text external">10.1136/bjo.2006.102541</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857552  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857552'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857552" class="external text external">1857552</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17179125  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17179125'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17179125" class="external text external">17179125</a>.</cite></span></li><li id="cite_note-McKee-88"> <span id="mw-reference-text-cite_note-McKee-88" class="mw-reference-text"><cite id="CITEREFMcKeeFergusonBentleyMarks2006" class="citation journal cs1">McKee EE, Ferguson M, Bentley AT, Marks TA (June 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479116  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479116'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479116" class="external text external">"Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>50</b> (6): 2042–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.01411-05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.01411-05'" tppabs="https://doi.org/10.1128%2FAAC.01411-05" class="external text external">10.1128/AAC.01411-05</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479116  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479116'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479116" class="external text external">1479116</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16723564  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16723564'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16723564" class="external text external">16723564</a>.</cite></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite id="CITEREFBishopMelvaniHowdenCharles2006" class="citation journal cs1">Bishop E, Melvani S, Howden BP, Charles PG, Grayson ML (April 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1426936  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1426936'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1426936" class="external text external">"Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>50</b> (4): 1599–602. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.50.4.1599-1602.2006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.50.4.1599-1602.2006'" tppabs="https://doi.org/10.1128%2FAAC.50.4.1599-1602.2006" class="external text external">10.1128/AAC.50.4.1599-1602.2006</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1426936  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1426936'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1426936" class="external text external">1426936</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16569895  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16569895'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16569895" class="external text external">16569895</a>.</cite></span></li><li id="cite_note-90"> <span id="mw-reference-text-cite_note-90" class="mw-reference-text"><cite id="CITEREFKingAttardi1989" class="citation journal cs1">King MP, Attardi G (October 1989). "Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation". <i>Science</i>. <b>246</b> (4929): 500–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1126%2Fscience.2814477  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1126%2Fscience.2814477'" tppabs="https://doi.org/10.1126%2Fscience.2814477" class="external text external">10.1126/science.2814477</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2814477  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2814477'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2814477" class="external text external">2814477</a>.</cite></span></li><li id="cite_note-91"> <span id="mw-reference-text-cite_note-91" class="mw-reference-text"><cite id="CITEREFLawrenceAdraGillman2006" class="citation journal cs1">Lawrence KR, Adra M, Gillman PK (June 2006). <a href="javascript:if(confirm('https://doi.org/10.1086/503839  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/503839'" tppabs="https://doi.org/10.1086/503839" class="external text external">"Serotonin toxicity associated with the use of linezolid: a review of postmarketing data"</a>. <i>Clinical Infectious Diseases</i>. <b>42</b> (11): 1578–83. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F503839  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F503839'" tppabs="https://doi.org/10.1086%2F503839" class="external text external">10.1086/503839</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16652315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16652315'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16652315" class="external text external">16652315</a>.</cite></span></li><li id="cite_note-Huang-92"> <span id="mw-reference-text-cite_note-Huang-92" class="mw-reference-text"><cite id="CITEREFHuangGortney2006" class="citation journal cs1">Huang V, Gortney JS (December 2006). "Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists". <i>Pharmacotherapy</i>. <b>26</b> (12): 1784–93. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.26.12.1784  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.26.12.1784'" tppabs="https://doi.org/10.1592%2Fphco.26.12.1784" class="external text external">10.1592/phco.26.12.1784</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17125439  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17125439'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17125439" class="external text external">17125439</a>.</cite></span></li><li id="cite_note-93"> <span id="mw-reference-text-cite_note-93" class="mw-reference-text"><cite id="CITEREFWaknine,_Yael2008" class="citation web cs1">Waknine, Yael (5 September 2008). <a href="javascript:if(confirm('http://www.medscape.com/viewarticle/580101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/580101'" tppabs="http://www.medscape.com/viewarticle/580101" class="external text external">"FDA Safety Changes: Mirena, Zyvox, Orencia"</a>. Medscape. <a href="javascript:if(confirm('https://web.archive.org/web/20081202190427/http://www.medscape.com/viewarticle/580101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20081202190427/http://www.medscape.com/viewarticle/580101'" tppabs="https://web.archive.org/web/20081202190427/http://www.medscape.com/viewarticle/580101" class="external text external">Archived</a> from the original on 2 December 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">6 September</span> 2008</span>.</cite> Freely available with registration.</span></li><li id="cite_note-Stalker-94"> <span id="mw-reference-text-cite_note-Stalker-94" class="mw-reference-text"><cite id="CITEREFStalkerJungbluth2003" class="citation journal cs1">Stalker DJ, Jungbluth GL (2003). "Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial". <i>Clinical Pharmacokinetics</i>. <b>42</b> (13): 1129–40. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200342130-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200342130-00004'" tppabs="https://doi.org/10.2165%2F00003088-200342130-00004" class="external text external">10.2165/00003088-200342130-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14531724  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14531724'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14531724" class="external text external">14531724</a>.</cite></span></li><li id="cite_note-Oxazolidinones_MAOI_2010_review-95"> <span id="mw-reference-text-cite_note-Oxazolidinones_MAOI_2010_review-95" class="mw-reference-text"><cite id="CITEREFRenslo2010" class="citation journal cs1">Renslo AR (May 2010). "Antibacterial oxazolidinones: emerging structure-toxicity relationships". <i>Expert Review of Anti-infective Therapy</i>. <b>8</b> (5): 565–74. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2Feri.10.26  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2Feri.10.26'" tppabs="https://doi.org/10.1586%2Feri.10.26" class="external text external">10.1586/eri.10.26</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20455685  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20455685'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20455685" class="external text external">20455685</a>.</cite></span></li><li id="cite_note-Tedizolid_and_oxazolidinones_2015_review-96"> <span id="mw-reference-text-cite_note-Tedizolid_and_oxazolidinones_2015_review-96" class="mw-reference-text"><cite id="CITEREFZhanelLoveAdamGolden2015" class="citation journal cs1">Zhanel GG, Love R, Adam H, Golden A, Zelenitsky S, Schweizer F, Gorityala B, Lagacé-Wiens PR, Rubinstein E, Walkty A, Gin AS, Gilmour M, Hoban DJ, Lynch JP, Karlowsky JA (February 2015). "Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens". <i>Drugs</i>. <b>75</b> (3): 253–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40265-015-0352-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40265-015-0352-7'" tppabs="https://doi.org/10.1007%2Fs40265-015-0352-7" class="external text external">10.1007/s40265-015-0352-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25673021  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25673021'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25673021" class="external text external">25673021</a>.</cite></span></li><li id="cite_note-97"> <span id="mw-reference-text-cite_note-97" class="mw-reference-text"><cite id="CITEREFIppolitoKanyoWangFranceschi2008" class="citation journal cs1">Ippolito JA, Kanyo ZF, Wang D, Franceschi FJ, Moore PB, Steitz TA, Duffy EM (June 2008). "Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit". <i>Journal of Medicinal Chemistry</i>. <b>51</b> (12): 3353–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjm800379d  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjm800379d'" tppabs="https://doi.org/10.1021%2Fjm800379d" class="external text external">10.1021/jm800379d</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18494460  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18494460'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18494460" class="external text external">18494460</a>.</cite></span></li><li id="cite_note-98"> <span id="mw-reference-text-cite_note-98" class="mw-reference-text"><cite id="CITEREFWilsonSchluenzenHarmsStarosta2008" class="citation journal cs1">Wilson DN, Schluenzen F, Harms JM, Starosta AL, Connell SR, Fucini P (September 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533191  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533191'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533191" class="external text external">"The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>105</b> (36): 13339–44. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2008PNAS..10513339W  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2008PNAS..10513339W'" tppabs="https://ui.adsabs.harvard.edu/abs/2008PNAS..10513339W" class="external text external">2008PNAS..10513339W</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.0804276105  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.0804276105'" tppabs="https://doi.org/10.1073%2Fpnas.0804276105" class="external text external">10.1073/pnas.0804276105</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533191  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533191'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533191" class="external text external">2533191</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18757750  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18757750'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18757750" class="external text external">18757750</a>.</cite></span></li><li id="cite_note-Kalil_et_al-99"> <span id="mw-reference-text-cite_note-Kalil_et_al-99" class="mw-reference-text"><cite id="CITEREFKalilMurthyHermsenNeto2010" class="citation journal cs1">Kalil AC, Murthy MH, Hermsen ED, Neto FK, Sun J, Rupp ME (September 2010). <a href="javascript:if(confirm('https://semanticscholar.org/paper/6066d5371494d5b53af0e7dabc011357c5d7bf2a  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/6066d5371494d5b53af0e7dabc011357c5d7bf2a'" tppabs="https://semanticscholar.org/paper/6066d5371494d5b53af0e7dabc011357c5d7bf2a" class="external text external">"Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis"</a>. <i>Critical Care Medicine</i>. <b>38</b> (9): 1802–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FCCM.0b013e3181eb3b96  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FCCM.0b013e3181eb3b96'" tppabs="https://doi.org/10.1097%2FCCM.0b013e3181eb3b96" class="external text external">10.1097/CCM.0b013e3181eb3b96</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20639754  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20639754'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20639754" class="external text external">20639754</a>.</cite></span></li><li id="cite_note-Slatter-100"> <span id="mw-reference-text-cite_note-Slatter-100" class="mw-reference-text"><cite id="CITEREFSlatterStalkerFeenstraWelshman2001" class="citation journal cs1">Slatter JG, Stalker DJ, Feenstra KL, Welshman IR, Bruss JB, Sams JP,  et al. (August 2001). <a href="javascript:if(confirm('http://dmd.aspetjournals.org/content/29/8/1136.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://dmd.aspetjournals.org/content/29/8/1136.full.pdf'" tppabs="http://dmd.aspetjournals.org/content/29/8/1136.full.pdf" class="external text external">"Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of <span>[</span>(14)C<span>]</span>linezolid to healthy human subjects"</a> <span class="cs1-format">(PDF)</span>. <i>Drug Metabolism and Disposition</i>. <b>29</b> (8): 1136–45. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11454733  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11454733'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11454733" class="external text external">11454733</a>.</cite></span></li><li id="cite_note-Sisson-101"> <span id="mw-reference-text-cite_note-Sisson-101" class="mw-reference-text"><cite id="CITEREFSissonJungbluthHopkins2002" class="citation journal cs1">Sisson TL, Jungbluth GL, Hopkins NK (January 2002). "Age and sex effects on the pharmacokinetics of linezolid". <i>European Journal of Clinical Pharmacology</i>. <b>57</b> (11): 793–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00228-001-0380-y  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00228-001-0380-y'" tppabs="https://doi.org/10.1007%2Fs00228-001-0380-y" class="external text external">10.1007/s00228-001-0380-y</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11868801  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11868801'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11868801" class="external text external">11868801</a>.</cite></span></li><li id="cite_note-Bialvaei-102"> <span id="mw-reference-text-cite_note-Bialvaei-102" class="mw-reference-text"><cite id="CITEREFZahedi_BialvaeiRahbarYousefiAsgharzadeh2017" class="citation journal cs1">Zahedi Bialvaei A, Rahbar M, Yousefi M, Asgharzadeh M, Samadi Kafil H (February 2017). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkw450  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkw450'" tppabs="https://doi.org/10.1093/jac/dkw450" class="external text external">"Linezolid: a promising option in the treatment of Gram-positives"</a>. <i>The Journal of Antimicrobial Chemotherapy</i>. <b>72</b> (2): 354–364. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkw450  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkw450'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkw450" class="external text external">10.1093/jac/dkw450</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27999068  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27999068'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27999068" class="external text external">27999068</a>.</cite></span></li><li id="cite_note-Brickner-103"> <span id="mw-reference-text-cite_note-Brickner-103" class="mw-reference-text"><cite id="CITEREFBrickner_SJ1996" class="citation journal cs1">Brickner SJ (1996). <a href="javascript:if(confirm('https://books.google.com/?id=_HFitfA4OcUC&pg=PA175&lpg=PA175  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=_HFitfA4OcUC&pg=PA175&lpg=PA175'" tppabs="https://books.google.com/?id=_HFitfA4OcUC&pg=PA175&lpg=PA175" class="external text external">"Oxazolidinone antibacterial agents"</a>. <i>Current Pharmaceutical Design</i>. <b>2</b> (2): 175–94.</cite> Detailed review of the discovery and development of the whole oxazolidinone class, including information on synthesis and structure-activity relationships.</span></li><li id="cite_note-104"> <span id="mw-reference-text-cite_note-104" class="mw-reference-text"><cite id="CITEREFEuropean_Medicines_Agency2011" class="citation web cs1">European Medicines Agency (2011). <a href="javascript:if(confirm('http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000944/WC500120736.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000944/WC500120736.pdf'" tppabs="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000944/WC500120736.pdf" class="external text external">"CHP Assessment Report for Xarelto (EMA/CHMP/301607/2011)"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20120130062132/http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000944/WC500120736.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120130062132/http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000944/WC500120736.pdf'" tppabs="https://web.archive.org/web/20120130062132/http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000944/WC500120736.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 30 January 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">15 March</span> 2012</span>.</cite></span></li><li id="cite_note-Xu-105"> <span id="mw-reference-text-cite_note-Xu-105" class="mw-reference-text"><cite id="CITEREFXuZhouXu2006" class="citation journal cs1">Xu GY, Zhou Y, Xu MC (2006). <a href="javascript:if(confirm('https://web.archive.org/web/20110707013015/http://www.imm.ac.cn/journal/ccl/1703/170306-302-b050449-p3.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110707013015/http://www.imm.ac.cn/journal/ccl/1703/170306-302-b050449-p3.pdf'" tppabs="https://web.archive.org/web/20110707013015/http://www.imm.ac.cn/journal/ccl/1703/170306-302-b050449-p3.pdf" class="external text external">"A convenient synthesis of antibacterial linezolid from (<i>S</i>)-glyceraldehyde acetonide"</a> <span class="cs1-format">(PDF)</span>. <i>Chinese Chemical Letters</i>. <b>17</b> (3): 302–4. Archived from <a href="javascript:if(confirm('http://www.imm.ac.cn/journal/ccl/1703/170306-302-b050449-p3.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.imm.ac.cn/journal/ccl/1703/170306-302-b050449-p3.pdf'" tppabs="http://www.imm.ac.cn/journal/ccl/1703/170306-302-b050449-p3.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 7 July 2011.</cite></span></li><li id="cite_note-Kaiser-106"> <span id="mw-reference-text-cite_note-Kaiser-106" class="mw-reference-text"><cite id="CITEREFKaiserCunicoPinheirode_Oliveira2007" class="citation journal cs1">Kaiser CR, Cunico W, Pinheiro AC, de Oliveira AG, Peralta MA, de Souza MV (2007). <a href="javascript:if(confirm('https://www.webcitation.org/67ft9fcH1?url=http://www.rbfarma.org.br/images/edicoes-em-pdf/2007/RBF_V88_N2_2007/PAG83a88_OXAZOLIDINONAS.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.webcitation.org/67ft9fcH1?url=http://www.rbfarma.org.br/images/edicoes-em-pdf/2007/RBF_V88_N2_2007/PAG83a88_OXAZOLIDINONAS.pdf'" tppabs="https://www.webcitation.org/67ft9fcH1?url=http://www.rbfarma.org.br/images/edicoes-em-pdf/2007/RBF_V88_N2_2007/PAG83a88_OXAZOLIDINONAS.pdf" class="external text external">"Oxazolidinonas: uma nova classe de compostos no combate à tuberculose"</a> <span>[</span>Oxazolidinones: a new class of compounds against tuberculosis<span>]</span> <span class="cs1-format">(PDF)</span>. <i>Revista Brasileira de Farmácia</i> (in Portuguese). <b>88</b> (2): 83–8. Archived from <a href="javascript:if(confirm('http://www.rbfarma.org.br/images/edicoes-em-pdf/2007/RBF_V88_N2_2007/PAG83a88_OXAZOLIDINONAS.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rbfarma.org.br/images/edicoes-em-pdf/2007/RBF_V88_N2_2007/PAG83a88_OXAZOLIDINONAS.pdf'" tppabs="http://www.rbfarma.org.br/images/edicoes-em-pdf/2007/RBF_V88_N2_2007/PAG83a88_OXAZOLIDINONAS.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 15 May 2012.</cite></span></li><li id="cite_note-107"> <span id="mw-reference-text-cite_note-107" class="mw-reference-text"><span class="citation patent" id="CITEREFPearlman_BA,_Perrault_WR,_Barbachyn_MR,_et_al.1997"><a href="javascript:if(confirm('https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=US5837870  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=US5837870'" tppabs="https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=US5837870" class="external text external">US<span> </span>patent 5837870</a>,<span> </span>Pearlman BA, Perrault WR, Barbachyn MR, <i>et al.</i>,<span> </span>"Process to prepare oxazolidinones",<span> </span>issued 1997-03-28</span> Retrieved on 13 June 2009.</span></li><li id="cite_note-108"> <span id="mw-reference-text-cite_note-108" class="mw-reference-text"><cite id="CITEREFLohrayBaskaranRaoReddy1999" class="citation journal cs1">Lohray BB, Baskaran S, Rao BS, Reddy BY, Rao IN (June 1999). "A short synthesis of oxazolidinone derivatives linezolid and eperezolid: A new class of antibacterials". <i>Tetrahedron Letters</i>. <b>40</b> (26): 4855–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0040-4039%2899%2900893-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0040-4039%2899%2900893-X'" tppabs="https://doi.org/10.1016%2FS0040-4039%2899%2900893-X" class="external text external">10.1016/S0040-4039(99)00893-X</a>.</cite></span></li><li id="cite_note-109"> <span id="mw-reference-text-cite_note-109" class="mw-reference-text">Perrault WR, Keeler JB, Snyder WC, <i>et al.</i> (25 June 2008). <a href="javascript:if(confirm('http://acs.confex.com/acs/green08/techprogram/P52019.HTM  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://acs.confex.com/acs/green08/techprogram/P52019.HTM'" tppabs="http://acs.confex.com/acs/green08/techprogram/P52019.HTM" class="external text external">"Convergent green synthesis of linezolid (Zyvox)"</a> <a href="javascript:if(confirm('https://web.archive.org/web/20110728022612/http://acs.confex.com/acs/green08/techprogram/P52019.HTM  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110728022612/http://acs.confex.com/acs/green08/techprogram/P52019.HTM'" tppabs="https://web.archive.org/web/20110728022612/http://acs.confex.com/acs/green08/techprogram/P52019.HTM" class="external text external">Archived</a><span> 28 July 2011 at the </span>Wayback Machine, in <i>12th Annual Green Chemistry and Engineering Conference</i>, 24–26 June 2008, New York, NY. Retrieved on 8 June 2009.</span></li><li id="cite_note-110"> <span id="mw-reference-text-cite_note-110" class="mw-reference-text"><cite id="CITEREFTsiodrasGoldSakoulas2001" class="citation journal cs1">Tsiodras S, Gold HS, Sakoulas G,  et al. (July 2001). "Linezolid resistance in a clinical isolate of <i>Staphylococcus aureus</i>". <i>The Lancet</i>. <b>358</b> (9277): 207–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2801%2905410-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2801%2905410-1'" tppabs="https://doi.org/10.1016%2FS0140-6736%2801%2905410-1" class="external text external">10.1016/S0140-6736(01)05410-1</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0140-6736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0140-6736'" tppabs="https://www.worldcat.org/issn/0140-6736" class="external text external">0140-6736</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11476839  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11476839'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11476839" class="external text external">11476839</a>.</cite></span></li><li id="cite_note-autogenerated1-111"> <span id="mw-reference-text-cite_note-autogenerated1-111" class="mw-reference-text"><cite id="CITEREFJonesRossCastanheiraMendes2008" class="citation journal cs1">Jones RN, Ross JE, Castanheira M, Mendes RE (December 2008). "United States resistance surveillance results for linezolid (LEADER Program for 2007)". <i>Diagnostic Microbiology and Infectious Disease</i>. <b>62</b> (4): 416–26. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.diagmicrobio.2008.10.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.diagmicrobio.2008.10.010'" tppabs="https://doi.org/10.1016%2Fj.diagmicrobio.2008.10.010" class="external text external">10.1016/j.diagmicrobio.2008.10.010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19022153  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19022153'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19022153" class="external text external">19022153</a>.</cite></span></li><li id="cite_note-ZAAPS2007-112"> <span id="mw-reference-text-cite_note-ZAAPS2007-112" class="mw-reference-text"><cite id="CITEREFJonesKohnoOnoRoss2009" class="citation journal cs1">Jones RN, Kohno S, Ono Y, Ross JE, Yanagihara K (June 2009). "ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries". <i>Diagnostic Microbiology and Infectious Disease</i>. <b>64</b> (2): 191–201. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.diagmicrobio.2009.03.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.diagmicrobio.2009.03.001'" tppabs="https://doi.org/10.1016%2Fj.diagmicrobio.2009.03.001" class="external text external">10.1016/j.diagmicrobio.2009.03.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19500528  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19500528'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19500528" class="external text external">19500528</a>.</cite></span></li><li id="cite_note-113"> <span id="mw-reference-text-cite_note-113" class="mw-reference-text"><cite id="CITEREFHopeLivermoreBrickLillie2008" class="citation journal cs1">Hope R, Livermore DM, Brick G, Lillie M, Reynolds R (November 2008). <a href="javascript:if(confirm('http://jac.oxfordjournals.org/content/62/suppl_2/ii65.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jac.oxfordjournals.org/content/62/suppl_2/ii65.full.pdf'" tppabs="http://jac.oxfordjournals.org/content/62/suppl_2/ii65.full.pdf" class="external text external">"Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001–06"</a> <span class="cs1-format">(PDF)</span>. <i>The Journal of Antimicrobial Chemotherapy</i>. 62 Suppl 2 (Suppl 2): ii65–74. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkn353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkn353'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkn353" class="external text external">10.1093/jac/dkn353</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18819981  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18819981'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18819981" class="external text external">18819981</a>.</cite></span></li><li id="cite_note-114"> <span id="mw-reference-text-cite_note-114" class="mw-reference-text"><cite id="CITEREFAucklandTeareCookeKaufmann2002" class="citation journal cs1">Auckland C, Teare L, Cooke F, Kaufmann ME, Warner M, Jones G, Bamford K, Ayles H, Johnson AP (November 2002). <a href="javascript:if(confirm('https://semanticscholar.org/paper/927462f8daa048bf33c8f41874a5d6296b74f690  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/927462f8daa048bf33c8f41874a5d6296b74f690'" tppabs="https://semanticscholar.org/paper/927462f8daa048bf33c8f41874a5d6296b74f690" class="external text external">"Linezolid-resistant enterococci: report of the first isolates in the United Kingdom"</a>. <i>The Journal of Antimicrobial Chemotherapy</i>. <b>50</b> (5): 743–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkf246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkf246'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkf246" class="external text external">10.1093/jac/dkf246</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12407134  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12407134'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12407134" class="external text external">12407134</a>.</cite></span></li><li id="cite_note-Scheetz-115"> <span id="mw-reference-text-cite_note-Scheetz-115" class="mw-reference-text"><cite id="CITEREFScheetzKnechtelMalczynskiPostelnick2008" class="citation journal cs1">Scheetz MH, Knechtel SA, Malczynski M, Postelnick MJ, Qi C (June 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2415807  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2415807'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2415807" class="external text external">"Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>52</b> (6): 2256–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.00070-08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.00070-08'" tppabs="https://doi.org/10.1128%2FAAC.00070-08" class="external text external">10.1128/AAC.00070-08</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2415807  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2415807'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2415807" class="external text external">2415807</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18391028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18391028'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18391028" class="external text external">18391028</a>.</cite></span></li><li id="cite_note-116"> <span id="mw-reference-text-cite_note-116" class="mw-reference-text"><cite id="CITEREFSchumacherTrittlerBohnertKümmerer2007" class="citation journal cs1">Schumacher A, Trittler R, Bohnert JA, Kümmerer K, Pagès JM, Kern WV (June 2007). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkl380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkl380'" tppabs="https://doi.org/10.1093/jac/dkl380" class="external text external">"Intracellular accumulation of linezolid in <i>Escherichia coli</i>, <i>Citrobacter freundii</i> and <i>Enterobacter aerogenes</i>: role of enhanced efflux pump activity and inactivation"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>59</b> (6): 1261–4. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkl380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkl380'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkl380" class="external text external">10.1093/jac/dkl380</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16971414  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16971414'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16971414" class="external text external">16971414</a>.</cite></span></li><li id="cite_note-Saager-117"> <span id="mw-reference-text-cite_note-Saager-117" class="mw-reference-text"><cite id="CITEREFSaagerRohdeTimmerbeil2008" class="citation journal cs1">Saager B, Rohde H, Timmerbeil BS,  et al. (September 2008). "Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) <i>Enterococcus faecium</i> isolates using Pyrosequencing". <i>European Journal of Clinical Microbiology &amp; Infectious Diseases</i>. <b>27</b> (9): 873–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10096-008-0514-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10096-008-0514-6'" tppabs="https://doi.org/10.1007%2Fs10096-008-0514-6" class="external text external">10.1007/s10096-008-0514-6</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0934-9723  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0934-9723'" tppabs="https://www.worldcat.org/issn/0934-9723" class="external text external">0934-9723</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18421487  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18421487'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18421487" class="external text external">18421487</a>.</cite></span></li><li id="cite_note-Besier-118"> <span id="mw-reference-text-cite_note-Besier-118" class="mw-reference-text"><cite id="CITEREFBesierLudwigZanderBrade2008" class="citation journal cs1">Besier S, Ludwig A, Zander J, Brade V, Wichelhaus TA (April 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292563  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292563'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292563" class="external text external">"Linezolid Resistance in Staphylococcus aureus: Gene Dosage Effect, Stability, Fitness Costs, and Cross-Resistances"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>52</b> (4): 1570–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.01098-07  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.01098-07'" tppabs="https://doi.org/10.1128%2FAAC.01098-07" class="external text external">10.1128/AAC.01098-07</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292563  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292563'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292563" class="external text external">2292563</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18212098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18212098'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18212098" class="external text external">18212098</a>.</cite></span></li><li id="cite_note-Feng2009-119"> <span id="mw-reference-text-cite_note-Feng2009-119" class="mw-reference-text"><cite id="CITEREFFengLupienGingras2009" class="citation journal cs1">Feng J, Lupien A, Gingras H,  et al. (May 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704432  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704432'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704432" class="external text external">"Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance"</a>. <i>Genome Research</i>. <b>19</b> (7): 1214–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1101%2Fgr.089342.108  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1101%2Fgr.089342.108'" tppabs="https://doi.org/10.1101%2Fgr.089342.108" class="external text external">10.1101/gr.089342.108</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1088-9051  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1088-9051'" tppabs="https://www.worldcat.org/issn/1088-9051" class="external text external">1088-9051</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704432  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704432'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704432" class="external text external">2704432</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19351617  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19351617'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19351617" class="external text external">19351617</a>.</cite></span></li><li id="cite_note-120"> <span id="mw-reference-text-cite_note-120" class="mw-reference-text"><cite id="CITEREFLincopande_AlmeidaElmor_de_AraújoMamizuka2009" class="citation journal cs1">Lincopan N, de Almeida LM, Elmor de Araújo MR, Mamizuka EM (April 2009). "Linezolid resistance in <i>Staphylococcus epidermidis</i> associated with a G2603T mutation in the 23S rRNA gene". <i>International Journal of Antimicrobial Agents</i>. <b>34</b> (3): 281–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijantimicag.2009.02.023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijantimicag.2009.02.023'" tppabs="https://doi.org/10.1016%2Fj.ijantimicag.2009.02.023" class="external text external">10.1016/j.ijantimicag.2009.02.023</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0924-8579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0924-8579'" tppabs="https://www.worldcat.org/issn/0924-8579" class="external text external">0924-8579</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19376688  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19376688'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19376688" class="external text external">19376688</a>.</cite></span></li><li id="cite_note-121"> <span id="mw-reference-text-cite_note-121" class="mw-reference-text"><cite id="CITEREFLiakopoulosNeocleousKlapsa2009" class="citation journal cs1">Liakopoulos A, Neocleous C, Klapsa D,  et al. (July 2009). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkp167  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkp167'" tppabs="https://doi.org/10.1093/jac/dkp167" class="external text external">"A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of <i>Staphylococcus epidermidis</i>"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>64</b> (1): 206–7. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkp167  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkp167'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkp167" class="external text external">10.1093/jac/dkp167</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19429927  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19429927'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19429927" class="external text external">19429927</a>.</cite></span></li><li id="cite_note-Slee-122"> <span id="mw-reference-text-cite_note-Slee-122" class="mw-reference-text"><cite id="CITEREFSleeWuonolaMcRipley1987" class="citation journal cs1">Slee AM, Wuonola MA, McRipley RJ,  et al. (November 1987). <a href="javascript:if(confirm('http://aac.asm.org/cgi/reprint/31/11/1791.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://aac.asm.org/cgi/reprint/31/11/1791.pdf'" tppabs="http://aac.asm.org/cgi/reprint/31/11/1791.pdf" class="external text external">"Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721"</a> <span class="cs1-format">(PDF)</span>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>31</b> (11): 1791–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.31.11.1791  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.31.11.1791'" tppabs="https://doi.org/10.1128%2FAAC.31.11.1791" class="external text external">10.1128/AAC.31.11.1791</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC175041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC175041'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC175041" class="external text external">175041</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3435127  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3435127'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3435127" class="external text external">3435127</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20110611221908/http://aac.asm.org/cgi/reprint/31/11/1791.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110611221908/http://aac.asm.org/cgi/reprint/31/11/1791.pdf'" tppabs="https://web.archive.org/web/20110611221908/http://aac.asm.org/cgi/reprint/31/11/1791.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 11 June 2011.</cite></span></li><li id="cite_note-Ford-123"> <span id="mw-reference-text-cite_note-Ford-123" class="mw-reference-text"><cite id="CITEREFFordZurenkoBarbachyn2001" class="citation journal cs1">Ford CW, Zurenko GE, Barbachyn MR (August 2001). "The discovery of linezolid, the first oxazolidinone antibacterial agent". <i>Current Drug Targets. Infectious Disorders</i>. <b>1</b> (2): 181–99. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F1568005014606099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F1568005014606099'" tppabs="https://doi.org/10.2174%2F1568005014606099" class="external text external">10.2174/1568005014606099</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12455414  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12455414'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12455414" class="external text external">12455414</a>.</cite></span></li><li id="cite_note-124"> <span id="mw-reference-text-cite_note-124" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20080110042651/https://www.fda.gov/cder/foi/nda/2000/21130_Zyvox.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080110042651/https://www.fda.gov/cder/foi/nda/2000/21130_Zyvox.htm'" tppabs="https://web.archive.org/web/20080110042651/https://www.fda.gov/cder/foi/nda/2000/21130_Zyvox.htm" class="external text external">"Drug Approval Package: Zyvox"</a>. FDA Center for Drug Evaluation and Research. 20 November 2001. Archived from <a href="javascript:if(confirm('https://www.fda.gov/cder/foi/nda/2000/21130_Zyvox.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/cder/foi/nda/2000/21130_Zyvox.htm'" tppabs="https://www.fda.gov/cder/foi/nda/2000/21130_Zyvox.htm" class="external text external">the original</a> on 10 January 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">17 January</span> 2009</span>.</cite> Comprehensive review of the FDA approval process. Includes detailed reviews of the chemistry and pharmacology of linezolid, correspondence between the FDA and Pharmacia &amp; Upjohn, and administrative documents.</span></li><li id="cite_note-125"> <span id="mw-reference-text-cite_note-125" class="mw-reference-text"><cite id="CITEREFANVISA2000" class="citation web cs1">ANVISA (5 June 2000). <a href="javascript:if(confirm('https://web.archive.org/web/20110719081421/http://www.anvisa.gov.br/legis/resol/2000/474_00re.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110719081421/http://www.anvisa.gov.br/legis/resol/2000/474_00re.htm'" tppabs="https://web.archive.org/web/20110719081421/http://www.anvisa.gov.br/legis/resol/2000/474_00re.htm" class="external text external">"Resolução nº 474, de 5 de junho de 2000"</a> <span>[</span>Resolution number 474, of 5 June 2000<span>]</span> (in Portuguese). National Health Surveillance Agency. Archived from <a href="javascript:if(confirm('http://www.anvisa.gov.br/legis/resol/2000/474_00re.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.anvisa.gov.br/legis/resol/2000/474_00re.htm'" tppabs="http://www.anvisa.gov.br/legis/resol/2000/474_00re.htm" class="external text external">the original</a> on 19 July 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">19 May</span> 2009</span>.</cite></span></li><li id="cite_note-126"> <span id="mw-reference-text-cite_note-126" class="mw-reference-text"><cite id="CITEREFIrinodaNomuraHashimoto2002" class="citation journal cs1">Irinoda K, Nomura S, Hashimoto M (October 2002). <a href="javascript:if(confirm('https://doi.org/10.1254/fpj.120.245  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1254/fpj.120.245'" tppabs="https://doi.org/10.1254/fpj.120.245" class="external text external">"<span>[</span>Antimicrobial and clinical effect of linezolid (Zyvox), new class of synthetic antibacterial drug<span>]</span>"</a>. <i>Nippon Yakurigaku Zasshi</i> (in Japanese). <b>120</b> (4): 245–52. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1254%2Ffpj.120.245  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1254%2Ffpj.120.245'" tppabs="https://doi.org/10.1254%2Ffpj.120.245" class="external text external">10.1254/fpj.120.245</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0015-5691  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0015-5691'" tppabs="https://www.worldcat.org/issn/0015-5691" class="external text external">0015-5691</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12425150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12425150'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12425150" class="external text external">12425150</a>.</cite></span></li><li id="cite_note-CanadaApproval-127"> <span id="mw-reference-text-cite_note-CanadaApproval-127" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('http://www.docguide.com/news/content.nsf/news/917912FCF5C34DCA85256A46006E24B0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.docguide.com/news/content.nsf/news/917912FCF5C34DCA85256A46006E24B0'" tppabs="http://www.docguide.com/news/content.nsf/news/917912FCF5C34DCA85256A46006E24B0" class="external text external">"Canada Approves Marketing Of Zyvoxam (Linezolid) For Gram Positive Infections"</a> (Press release). 8 May 2001. <a href="javascript:if(confirm('https://web.archive.org/web/20080828012714/http://www.docguide.com/news/content.nsf/news/917912FCF5C34DCA85256A46006E24B0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080828012714/http://www.docguide.com/news/content.nsf/news/917912FCF5C34DCA85256A46006E24B0'" tppabs="https://web.archive.org/web/20080828012714/http://www.docguide.com/news/content.nsf/news/917912FCF5C34DCA85256A46006E24B0" class="external text external">Archived</a> from the original on 28 August 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">18 May</span> 2009</span>.</cite></span></li><li id="cite_note-128"> <span id="mw-reference-text-cite_note-128" class="mw-reference-text"><cite id="CITEREFKarlowskyKellyCritchleyJones2002" class="citation journal cs1">Karlowsky JA, Kelly LJ, Critchley IA, Jones ME, Thornsberry C, Sahm DF (June 2002). <a href="javascript:if(confirm('http://aac.asm.org/cgi/reprint/46/6/1989.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://aac.asm.org/cgi/reprint/46/6/1989.pdf'" tppabs="http://aac.asm.org/cgi/reprint/46/6/1989.pdf" class="external text external">"Determining Linezolid's Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release"</a> <span class="cs1-format">(PDF)</span>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>46</b> (6): 1989–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.46.6.1989-1992.2002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.46.6.1989-1992.2002'" tppabs="https://doi.org/10.1128%2FAAC.46.6.1989-1992.2002" class="external text external">10.1128/AAC.46.6.1989-1992.2002</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0066-4804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0066-4804'" tppabs="https://www.worldcat.org/issn/0066-4804" class="external text external">0066-4804</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127260  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127260'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC127260" class="external text external">127260</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12019122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12019122'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12019122" class="external text external">12019122</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20110929102627/http://aac.asm.org/cgi/reprint/46/6/1989.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110929102627/http://aac.asm.org/cgi/reprint/46/6/1989.pdf'" tppabs="https://web.archive.org/web/20110929102627/http://aac.asm.org/cgi/reprint/46/6/1989.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 29 September 2011.</cite></span></li><li id="cite_note-129"> <span id="mw-reference-text-cite_note-129" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120509230639/http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=%2Fwww%2Fstory%2F07-25-2001%2F0001540814&EDATE=  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120509230639/http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=%2Fwww%2Fstory%2F07-25-2001%2F0001540814&EDATE='" tppabs="https://web.archive.org/web/20120509230639/http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=%2Fwww%2Fstory%2F07-25-2001%2F0001540814&EDATE=" class="external text external">"Pharmacia Corporation Reports 17% Increase In Second-Quarter Earnings-Per-Share Driven By 61% Increase In Pharmaceutical Earnings"</a> (Press release). Pharmacia Corporation. 25 July 2001. Archived from <a href="javascript:if(confirm('http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-25-2001/0001540814&EDATE=  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-25-2001/0001540814&EDATE='" tppabs="http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-25-2001/0001540814&EDATE=" class="external text external">the original</a> on 9 May 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">19 May</span> 2009</span>.</cite></span></li><li id="cite_note-Livermore2009-130"> <span id="mw-reference-text-cite_note-Livermore2009-130" class="mw-reference-text"><cite id="CITEREFLivermoreMushtaqWarnerWoodford2009" class="citation journal cs1">Livermore DM, Mushtaq S, Warner M, Woodford N (April 2009). <a href="javascript:if(confirm('https://doi.org/10.1093/jac/dkp002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jac/dkp002'" tppabs="https://doi.org/10.1093/jac/dkp002" class="external text external">"Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci"</a>. <i>Journal of Antimicrobial Chemotherapy</i>. <b>63</b> (4): 713–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkp002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkp002'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkp002" class="external text external">10.1093/jac/dkp002</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0305-7453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0305-7453'" tppabs="https://www.worldcat.org/issn/0305-7453" class="external text external">0305-7453</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19164418  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19164418'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19164418" class="external text external">19164418</a>.</cite></span></li><li id="cite_note-131"> <span id="mw-reference-text-cite_note-131" class="mw-reference-text"><cite id="CITEREFHoweWoottonNoelBowker2003" class="citation journal cs1">Howe RA, Wootton M, Noel AR, Bowker KE, Walsh TR, MacGowan AP (November 2003). <a href="javascript:if(confirm('http://aac.asm.org/cgi/reprint/47/11/3651.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://aac.asm.org/cgi/reprint/47/11/3651.pdf'" tppabs="http://aac.asm.org/cgi/reprint/47/11/3651.pdf" class="external text external">"Activity of AZD2563, a Novel Oxazolidinone, against Staphylococcus aureus Strains with Reduced Susceptibility to Vancomycin or Linezolid"</a> <span class="cs1-format">(PDF)</span>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>47</b> (11): 3651–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.47.11.3651-3652.2003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.47.11.3651-3652.2003'" tppabs="https://doi.org/10.1128%2FAAC.47.11.3651-3652.2003" class="external text external">10.1128/AAC.47.11.3651-3652.2003</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0066-4804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0066-4804'" tppabs="https://www.worldcat.org/issn/0066-4804" class="external text external">0066-4804</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC253812  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC253812'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC253812" class="external text external">253812</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14576139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14576139'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14576139" class="external text external">14576139</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20110929080102/http://aac.asm.org/cgi/reprint/47/11/3651.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110929080102/http://aac.asm.org/cgi/reprint/47/11/3651.pdf'" tppabs="https://web.archive.org/web/20110929080102/http://aac.asm.org/cgi/reprint/47/11/3651.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 29 September 2011.</cite></span></li><li id="cite_note-132"> <span id="mw-reference-text-cite_note-132" class="mw-reference-text"><cite id="CITEREFKaliaMiglaniPurnapatre2009" class="citation journal cs1">Kalia V, Miglani R, Purnapatre KP,  et al. (April 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663096  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663096'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663096" class="external text external">"Mode of Action of Ranbezolid against Staphylococci and Structural Modeling Studies of Its Interaction with Ribosomes"</a>. <i>Antimicrobial Agents and Chemotherapy</i>. <b>53</b> (4): 1427–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1128%2FAAC.00887-08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1128%2FAAC.00887-08'" tppabs="https://doi.org/10.1128%2FAAC.00887-08" class="external text external">10.1128/AAC.00887-08</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0066-4804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0066-4804'" tppabs="https://www.worldcat.org/issn/0066-4804" class="external text external">0066-4804</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663096  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663096'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663096" class="external text external">2663096</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19075051  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19075051'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19075051" class="external text external">19075051</a>.</cite></span></li><li id="cite_note-133"> <span id="mw-reference-text-cite_note-133" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20090226201337/http://www.rib-x.com/pipeline/rx_1741  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090226201337/http://www.rib-x.com/pipeline/rx_1741'" tppabs="https://web.archive.org/web/20090226201337/http://www.rib-x.com/pipeline/rx_1741" class="external text external">"Rx 1741"</a>. Rib-X Pharmaceuticals. 2009. Archived from <a href="javascript:if(confirm('http://www.rib-x.com/pipeline/rx_1741  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rib-x.com/pipeline/rx_1741'" tppabs="http://www.rib-x.com/pipeline/rx_1741" class="external text external">the original</a> on 26 February 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">17 May</span> 2009</span>.</cite></span></li><li id="cite_note-134"> <span id="mw-reference-text-cite_note-134" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205436orig1s000approv.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205436orig1s000approv.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205436orig1s000approv.pdf" class="external text external">"Approval Package for: application number: 205436Orig1s000"</a> <span class="cs1-format">(PDF)</span>. Food and Drug Administration. 20 June 2014.</cite></span></li><li id="cite_note-Medi2016-135"> <span id="mw-reference-text-cite_note-Medi2016-135" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-07/ry9m-tx78  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-07/ry9m-tx78'" tppabs="https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-07/ry9m-tx78" class="external text external">"NADAC as of 2016-12-07"</a>. <i>Centers for Medicare and Medicaid Services</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20161221003023/https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-07/ry9m-tx78  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161221003023/https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-07/ry9m-tx78'" tppabs="https://web.archive.org/web/20161221003023/https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-07/ry9m-tx78" class="external text external">Archived</a> from the original on 21 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">11 December</span> 2016</span>.</cite></span></li><li id="cite_note-136"> <span id="mw-reference-text-cite_note-136" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://news.bbc.co.uk/2/hi/business/8234533.stm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://news.bbc.co.uk/2/hi/business/8234533.stm'" tppabs="http://news.bbc.co.uk/2/hi/business/8234533.stm" class="external text external">"Pfizer agrees record fraud fine"</a>. BBC News. 2 September 2009. <a href="javascript:if(confirm('https://web.archive.org/web/20090908011344/http://news.bbc.co.uk/2/hi/business/8234533.stm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090908011344/http://news.bbc.co.uk/2/hi/business/8234533.stm'" tppabs="https://web.archive.org/web/20090908011344/http://news.bbc.co.uk/2/hi/business/8234533.stm" class="external text external">Archived</a> from the original on 8 September 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">12 September</span> 2009</span>.</cite></span></li><li id="cite_note-137"> <span id="mw-reference-text-cite_note-137" class="mw-reference-text"><cite id="CITEREFHarris2009" class="citation news cs1">Harris G (2 September 2009). <a href="javascript:if(confirm('https://www.nytimes.com/2009/09/03/business/03health.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2009/09/03/business/03health.html'" tppabs="https://www.nytimes.com/2009/09/03/business/03health.html" class="external text external">"Pfizer pays $2.3 billion to settle marketing case"</a>. <i>The New York Times</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20110822013720/http://www.nytimes.com/2009/09/03/business/03health.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110822013720/http://www.nytimes.com/2009/09/03/business/03health.html'" tppabs="https://web.archive.org/web/20110822013720/http://www.nytimes.com/2009/09/03/business/03health.html" class="external text external">Archived</a> from the original on 22 August 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">12 September</span> 2009</span>.</cite></span></li><li id="cite_note-Name2018Int-138"> <span id="mw-reference-text-cite_note-Name2018Int-138" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/linezolid.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/linezolid.html'" tppabs="https://www.drugs.com/international/linezolid.html" class="external text external">"Linezolid"</a>. <i>Drugs.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">29 December</span> 2018</span>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/linezolid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/linezolid'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/linezolid" class="external text external">"Linezolid"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antibacterials_that_inhibit_protein_synthesis_(J01A,_J01B,_J01F,_J01G,_QJ01XQ)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antibacterials_that_inhibit_protein_synthesis_(J01A,_J01B,_J01F,_J01G,_QJ01XQ)" style="font-size:114%;margin:0 4em">Antibacterials that inhibit protein synthesis (J01A, J01B, J01F, J01G, QJ01XQ)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">30S</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Aminoglycosides<br>(initiation inhibitors)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">-mycin (<i>Streptomyces</i>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Streptomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Streptomycin" title="Streptomycin">Streptomycin</a><sup>#</sup></li>
<li>Dihydrostreptomycin</li></ul>

<ul><li><a href="Neomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Neomycin" title="Neomycin">Neomycin</a><sup>#</sup>
<ul><li><a href="Framycetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Framycetin" title="Framycetin" class="mw-redirect">Framycetin</a></li>
<li>Paromomycin</li>
<li><a href="Ribostamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ribostamycin" title="Ribostamycin">Ribostamycin</a></li></ul></li></ul>

<ul><li><a href="Kanamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Kanamycin" title="Kanamycin" class="mw-redirect">Kanamycin</a>
<ul><li><a href="Amikacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Amikacin" title="Amikacin">Amikacin</a><sup>#</sup></li>
<li>Arbekacin</li>
<li><a href="Bekanamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bekanamycin" title="Bekanamycin">Bekanamycin</a></li>
<li>Dibekacin</li>
<li><a href="Tobramycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tobramycin" title="Tobramycin">Tobramycin</a></li></ul></li></ul>

<ul><li><a href="Spectinomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Spectinomycin" title="Spectinomycin">Spectinomycin</a><sup>#</sup></li>
<li><a href="Hygromycin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Hygromycin_B" title="Hygromycin B">Hygromycin B</a></li>
<li><a href="Apramycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apramycin" title="Apramycin">Apramycin</a></li>
<li><a href="Puromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Puromycin" title="Puromycin">Puromycin</a></li>
<li>Nourseothricin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">-micin (<i>Micromonospora</i>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Gentamicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gentamicin" title="Gentamicin">Gentamicin</a><sup>#</sup>
<ul><li><a href="Netilmicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Netilmicin" title="Netilmicin">Netilmicin</a></li>
<li>Sisomicin</li>
<li>Plazomicin<sup>†</sup></li>
<li>Isepamicin</li></ul></li></ul>

<ul><li>Verdamicin</li></ul>

<ul><li>Astromicin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tetracycline antibiotics<br>(tRNA binding)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Tetracyclines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Doxycycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxycycline" title="Doxycycline">Doxycycline</a><sup>#</sup></li>
<li>Chlortetracycline</li>
<li><a href="Clomocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomocycline" title="Clomocycline">Clomocycline</a></li>
<li><a href="Demeclocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Demeclocycline" title="Demeclocycline">Demeclocycline</a></li>
<li>Eravacycline</li>
<li><a href="Lymecycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Lymecycline" title="Lymecycline">Lymecycline</a></li>
<li>Meclocycline<sup>‡</sup></li>
<li><a href="Metacycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metacycline" title="Metacycline">Metacycline</a></li>
<li><a href="Minocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Minocycline" title="Minocycline">Minocycline</a></li>
<li>Omadacycline</li>
<li><a href="Oxytetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxytetracycline" title="Oxytetracycline">Oxytetracycline</a></li>
<li>Penimepicycline</li>
<li><a href="Rolitetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rolitetracycline" title="Rolitetracycline">Rolitetracycline</a></li>
<li>Sarecycline</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Glycylcyclines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Tigecycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tigecycline" title="Tigecycline">Tigecycline</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">50S</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="2-Oxazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Oxazolidone" title="2-Oxazolidone">Oxazolidinone</a><br>(initiation inhibitors)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Eperezolid</li>
<li><a href="Linezolid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linezolid" title="Linezolid">Linezolid</a><sup>#</sup></li>
<li>Posizolid</li>
<li>Radezolid</li>
<li>Ranbezolid</li>
<li>Sutezolid</li>
<li>Tedizolid</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Peptidyl transferase</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Amphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphenicol" title="Amphenicol">Amphenicols</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Chloramphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloramphenicol" title="Chloramphenicol">Chloramphenicol</a><sup>#</sup></li>
<li>Azidamfenicol</li>
<li><a href="Thiamphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiamphenicol" title="Thiamphenicol">Thiamphenicol</a></li>
<li><a href="Florfenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Florfenicol" title="Florfenicol">Florfenicol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pleuromutilins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Lefamulin</li>
<li><a href="Retapamulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Retapamulin" title="Retapamulin">Retapamulin</a></li>
<li>Tiamulin</li>
<li>Valnemulin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">MLS (transpeptidation/translocation)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Macrolides</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Azithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Azithromycin" title="Azithromycin">Azithromycin</a><sup>#</sup></li>
<li>Boromycin</li>
<li><a href="Clarithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clarithromycin" title="Clarithromycin">Clarithromycin</a><sup>#</sup></li>
<li><a href="Dirithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dirithromycin" title="Dirithromycin">Dirithromycin</a></li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a><sup>#</sup></li>
<li>Flurithromycin</li>
<li><a href="Josamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Josamycin" title="Josamycin">Josamycin</a></li>
<li>Midecamycin</li>
<li>Miocamycin</li>
<li><a href="Oleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleandomycin" title="Oleandomycin">Oleandomycin</a></li>
<li>Rokitamycin</li>
<li><a href="Roxithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Roxithromycin" title="Roxithromycin">Roxithromycin</a></li>
<li>Spiramycin</li>
<li><a href="Troleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li>
<li><a href="Tylosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tylosin" title="Tylosin">Tylosin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ketolides</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Telithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Telithromycin" title="Telithromycin">Telithromycin</a><sup>‡</sup></li>
<li>Cethromycin</li>
<li>Solithromycin<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Lincosamides</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">Clindamycin</a><sup>#</sup></li>
<li><a href="Lincomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lincomycin" title="Lincomycin">Lincomycin</a></li>
<li>Pirlimycin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Streptogramins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Pristinamycin</li>
<li>Quinupristin/dalfopristin</li>
<li>Virginiamycin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">EF-G</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Steroid_antibacterials" scope="row" class="navbox-group" style="width:1%">Steroid antibacterials</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Fusidic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fusidic_acid" title="Fusidic acid">Fusidic acid</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Monoamine_metabolism_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_metabolism_modulators" style="font-size:114%;margin:0 4em">Monoamine metabolism modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Non-specific</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>AAAD</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a>→<a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li><a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/5-HTP" title="5-HTP" class="mw-redirect">5-HTP</a>→<a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a></li>
<li><small>L</small>-Histidine→<a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a>→<a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><small>L</small>-Tyrosine→<a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">Tyramine</a></li>
<li><a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a>→<a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">Tryptamine</a></li></ul>

<ul><li><b>Inhibitors:</b> Benserazide</li>
<li><a href="Carbidopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbidopa" title="Carbidopa">Carbidopa</a></li>
<li>DFMD</li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>MAO</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products (with <abbr>ALDH</abbr>/<abbr>ALR</abbr>):</b> <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine (adrenaline)</a>→DHMA</li>
<li>Metanephrine→MHPG/<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li>Norepinephrine (noradrenaline)→DHMA</li>
<li>Normetanephrine→MHPG/<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→<a href="3,4-Dihydroxyphenylacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Dihydroxyphenylacetic_acid" title="3,4-Dihydroxyphenylacetic acid">DOPAC</a></li>
<li><a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a>→<a href="Homovanillic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Homovanillic_acid" title="Homovanillic acid">HVA</a></li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a>→<a href="5-Hydroxyindoleacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Hydroxyindoleacetic_acid" title="5-Hydroxyindoleacetic acid">5-HIAA</a></li></ul>

<ul><li><b>Inhibitors:</b> <i>Non-selective:</i> Benmoxin</li>
<li>Caroxazone</li>
<li>Echinopsidine</li>
<li><a href="Furazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazolidone" title="Furazolidone">Furazolidone</a></li>
<li>Guineesine</li>
<li><a href="Hydralazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydralazine" title="Hydralazine">Hydralazine</a></li>
<li>Indantadol</li>
<li>Iproclozide</li>
<li><a href="Iproniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Iproniazid" title="Iproniazid">Iproniazid</a></li>
<li><a href="Isocarboxazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a></li>
<li><a href="Isoniazid.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoniazid" title="Isoniazid">Isoniazid</a></li>
<li><a href="Linezolid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linezolid" title="Linezolid">Linezolid</a></li>
<li>Mebanazine</li>
<li>Metfendrazine</li>
<li><a href="Nialamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nialamide" title="Nialamide">Nialamide</a></li>
<li>Octamoxin</li>
<li>Paraxazone</li>
<li><a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">Phenelzine</a></li>
<li>Pheniprazine</li>
<li>Phenoxypropazine</li>
<li>Pivhydrazine</li>
<li><a href="Procarbazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procarbazine" title="Procarbazine">Procarbazine</a></li>
<li>Safrazine</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <i>MAO-A-selective:</i> Amiflamine</li>
<li>Bazinaprine</li>
<li>Befloxatone</li>
<li>Brofaromine</li>
<li>Cimoxatone</li>
<li><a href="Clorgiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorgiline" title="Clorgiline">Clorgiline</a></li>
<li>CX157 (Tyrima)</li>
<li>Eprobemide</li>
<li>Esuprone</li>
<li><a href="Harmala_alkaloid.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmala_alkaloid" title="Harmala alkaloid">Harmala alkaloids</a> (e.g., <a href="Harmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmine" title="Harmine">harmine</a>, <a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">harmaline</a>, harman, norharman, tetrahydroharmine)</li>
<li>Methylene blue</li>
<li>Metralindole</li>
<li><a href="Minaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Minaprine" title="Minaprine">Minaprine</a></li>
<li><a href="Moclobemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Moclobemide" title="Moclobemide">Moclobemide</a></li>
<li>Pirlindole</li>
<li>Sercloremine</li>
<li>Tetrindole</li>
<li>Toloxatone</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <i>MAO-B selective:</i> <span class="new">Adarigiline</span></li>
<li>Almoxatone</li>
<li><small>D</small>-Deprenyl</li>
<li><a href="Ethanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethanol" title="Ethanol">Ethanol</a></li>
<li>Ladostigil</li>
<li>Lazabemide</li>
<li>Milacemide</li>
<li>Mofegiline</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="Pargyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Pargyline" title="Pargyline">Pargyline</a><sup>‡</sup></li>
<li><a href="Rasagiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li>Safinamide</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline (<small>L</small>-Deprenyl)</a></li>
<li><span class="new">Sembragiline</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Phenethylamines<br><small>(<a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>, <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">epinephrine</a>,<br>norepinephrine)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>PAH</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a>→<a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a></li></ul>

<ul><li><b>Inhibitors:</b> 3,4-Dihydroxystyrene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>TH</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a>→<a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li></ul>

<ul><li><b>Inhibitors:</b> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li>3-Iodotyrosine</li>
<li>Aquayamycin</li>
<li>Bulbocapnine</li>
<li><a href="Metirosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Metirosine" title="Metirosine">Metirosine</a></li>
<li>Oudenone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>DBH</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→Norepinephrine (Noradrenaline)</li></ul>

<ul><li><b>Inhibitors:</b> Bupicomide</li>
<li><a href="Disulfiram.htm" tppabs="https://ptable.com/wiki/compounds/A/Disulfiram" title="Disulfiram">Disulfiram</a></li>
<li>Dopastin</li>
<li><a href="Fusaric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fusaric_acid" title="Fusaric acid">Fusaric acid</a></li>
<li>Nepicastat</li>
<li>Phenopicolinic acid</li>
<li><a href="Tropolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropolone" title="Tropolone">Tropolone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>PNMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> Norepinephrine (noradrenaline)→<a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine (adrenaline)</a></li></ul>

<ul><li><b>Inhibitors:</b> <span class="new">CGS-19281A</span></li>
<li><span class="new">SKF-64139</span></li>
<li><span class="new">SKF-7698</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>COMT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a>→<a href="3-Methoxytyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/3-Methoxytyramine" title="3-Methoxytyramine">3-Methoxytyramine</a></li>
<li><a href="3,4-Dihydroxyphenylacetic_acid-1.htm" tppabs="https://ptable.com/wiki/compounds/A/DOPAC" title="DOPAC" class="mw-redirect">DOPAC</a>→<a href="Homovanillic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Homovanillic_acid" title="Homovanillic acid">Homovanillic acid</a></li>
<li>Norepinephrine→Normetanephrine</li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a>→Metanephrine</li>
<li><a href="Dihydroxyphenylethylene_glycol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroxyphenylethylene_glycol" title="Dihydroxyphenylethylene glycol">DOPEG</a>→MOPEG</li>
<li>DOMA→<a href="Vanillylmandelic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanillylmandelic_acid" title="Vanillylmandelic acid">VMA</a></li>
<li>2-Hydroxyestradiol→<a href="2-Methoxyestradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li>
<li>2-Hydroxyestrone→2-Methoxyestrone</li>
<li>4-Hydroxyestradiol→4-Methoxyestradiol</li>
<li>4-Hydroxyestrone→4-Methoxyestrone</li></ul>

<ul><li><b>Inhibitors:</b> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li><a href="Entacapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Entacapone" title="Entacapone">Entacapone</a></li>
<li><span class="new">Neluxicapone</span></li>
<li><a href="Nitecapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitecapone" title="Nitecapone">Nitecapone</a></li>
<li>Opicapone</li>
<li><a href="Quinalizarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinalizarin" title="Quinalizarin">Quinalizarin</a></li>
<li><a href="Tolcapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolcapone" title="Tolcapone">Tolcapone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Tryptamines<br><small>(<a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a>, <a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">melatonin</a>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>TPH</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a>→<a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/5-HTP" title="5-HTP" class="mw-redirect">5-HTP</a></li></ul>

<ul><li><b>Inhibitors:</b> AGN-2979</li>
<li><a href="Fenclonine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenclonine" title="Fenclonine">Fenclonine (PCPA)</a></li>
<li>Telotristat ethyl</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>AANAT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a>→<a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">N-Acetylserotonin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>ASMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">N-Acetylserotonin</a>→<a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">Melatonin</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>HDC</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <small>L</small>-Histidine→<a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a></li></ul>

<ul><li><b>Inhibitors:</b> <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/(%2B)-Catechin" title="(+)-Catechin" class="mw-redirect">Catechin</a></li>
<li>Alpha-Fluoromethylhistidine</li>
<li>Histidine methyl ester</li>
<li>Meciadanol</li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li>Tritoqualine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>HNMT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a>→<span class="new">N-Methylhistamine</span></li></ul>

<ul><li><b>Inhibitors:</b> <a href="Amodiaquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amodiaquine" title="Amodiaquine">Amodiaquine</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li><a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">Harmaline</a></li>
<li><span class="new">Metoprine</span></li>
<li><a href="Quinacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinacrine" title="Quinacrine" class="mw-redirect">Quinacrine</a></li>
<li>SKF-91488</li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:4em;;text-align:center;"><abbr>DAO</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Substrates→Products:</b> <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">Histamine</a>→<span class="new">Imidazole acetic acid</span></li></ul>

<ul><li><b>Inhibitors:</b> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Pimagedine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Pimagedine'" tppabs="https://ptable.com/wiki/compounds/A/Pimagedine" title="Pimagedine">Pimagedine (aminoguanidine)</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><small><i><b>See also:</b> Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine neurotoxins</i></small></div></td></tr></tbody></table></div>
<p></p>













<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-04" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Linezolid&oldid=971214080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Linezolid&oldid=971214080'" tppabs="https://en.wikipedia.org/wiki/?title=Linezolid&oldid=971214080">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>